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Abstract 
Influenza viruses are human respiratory pathogens that cause seasonal epidemics 
and pandemics. The host restricts the virus infection by inducing immune responses 
aiming at virus clearance. The immune response has two arms. The innate immunity 
is the first line defense mechanism that is activated immediately after the recognition 
of the pathogen. The adaptive immunity, which consists of humoral and cell-
mediated immunity, takes more time to develop. The epithelial cells of the 
respiratory tract and innate immune cells, such as macrophages and dendritic cells, 
are equipped with a plethora of receptors and signaling molecules that are designed 
for pathogen recognition. These receptors include Toll-like receptors (TLRs) and 
RIG-I-like receptors (RLRs). The pathogen recognition by these receptors leads to 
the activation of complex cellular signaling cascades that culminate in the 
production of cytokines, small proteins that mediate the communication between 
cells. In influenza infection, one important class of cytokines is interferons (IFNs) 
which induce the production of antiviral proteins that are able to inhibit virus 
infection. On the other hand, influenza viruses are capable of evading innate 
immune surveillance and there are differences between influenza virus types or 
strains in their immune evasion mechanisms. 
In this thesis work influenza virus-induced IFN responses were studied in human 
macrophages and dendritic cells in vitro. Firstly, we showed that in macrophages 
influenza B virus infection induced a very early IFN-?????????-???????????????????
that coincided with the nuclear entry of the virus and the activation and nuclear 
import of IFN regulatory  factor 3 (IRF3). This early activation did not take place in 
influenza A virus-infected cells. Furthermore, our study indicated that RIG-I 
receptor was essential for the early IFN gene expression. Secondly, we compared the 
cytokine responses induced by pandemic H1N1 influenza A virus to the ones 
induced by seasonal influenza A viruses in human macrophages and dendritic cells. 
We showed that the pandemic influenza A virus induced weak IFN responses but 
was highly sensitive to the antiviral actions of IFNs. 
During the infection, different types of microbial structures are present and can be 
recognized by different cellular receptors. Another aim of this thesis was to 
elucidate the mechanism of receptor cooperation in inducing synergistic cytokine 
production. We confirmed the previous findings that TLR3 or TLR4 together with 
TLR7/8 induces synergistic interleukin (IL)-12 and IFN gene expression in human 
dendritic cells. We studied, which regulatory factors bound to IL-12 and IFN-???
gene promoters during a synergistic stimulation and which cell signaling pathways 
took part in the cytokine production. We conclude that at the transcriptional level, 
several different IRF proteins and cell signaling pathways cooperate in the 
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synergistic IL-12 and IFN-?? ????? ???????????? ??? ????????, we propose that IFNs 
produced after stimulation of the TLR3 pathway induce the expression of TLR7 
receptor and other cell signaling components that create a positive feedback loop 
that further augments the cytokine and IFN production during synergistic 
stimulation. 
This thesis discusses the host-pathogen interactions in the human system and 
clarifies the cell signaling pathways leading to synergistic cytokine gene expression. 
Moreover, the early events in influenza B virus infection and IFN responses induced 
by pandemic H1N1 influenza A virus are described. More detailed knowledge of the 
human innate immune responses induced by host-pathogen interactions is needed for 
the development of effective vaccines and antiviral treatments against influenza 
virus. 
Keywords: innate immunity, influenza, interferon, cytokine, Toll-like receptor, 
macrophage, dendritic cell 
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Tiivistelmä 
Influenssavirukset aiheuttavat vuosittaisia epidemioita ja ajoittain ilmaantuvia 
pandemioita. Influenssavirusinfektio saa aikaan hengitystietulehduksen, joka voi 
johtaa vakavaan tautiin perussairailla, immuunipuutteisilla tai iäkkäillä henkilöillä. 
Ihmisen immuunipuolustuksen tehokas aktivoituminen virusinfektiossa johtaa 
yleensä taudin paranemiseen. Elimistön immuunipuolustus voidaan jakaa 
synnynnäiseen eli luontaiseen sekä hankittuun eli adaptiiviseen immuniteettiin. 
Luontainen immuniteetti käynnistyy nopeasti heti taudinaiheuttajan havaitsemisen 
jälkeen, kun taas adaptiivisen vasta-aine- ja soluvälitteisen imuniteetin 
käynnistyminen tapahtuu hitaammin. Hengitysteiden epiteelisolut ja luontaisen 
immuniteetin solut, kuten makrofagit ja dendriittisolut, tunnistavat mikrobirakenteita 
reseptoreillaan. Tunnistus johtaa solunsisäisten viestintäketjujen käynnistymiseen, 
luontaisen immuniteetin geenien luennan aktivoitumiseen ja solujen viestiaineiden, 
sytokiinien tuottoon. Sytokiinit ohjaavat immuunipuolustuksen toimintaa monin 
tavoin; influenssainfektiossa tärkeitä sytokiinejä ovat interferonit, jotka saavat 
aikaan useiden virusta rajoittavien proteiinien tuotannon. Toisaalta influenssavirus 
kykenee monin tavoin estämään elimistön immuunipuolustuksen käynnistymistä ja 
toimintaa. 
Tässä työssä tutkittiin influenssavirusinfektion aikaansaamia interferonivasteita 
ihmisen immuunisolumallissa. Näytimme, että influenssa B-virus laukaisee hyvin 
nopean interferonivasteen, mikä tapahtuu selvästi influenssa A-viruksen aktivoimaa 
vastetta aikaisemmin. Ihmisen makrofageissa tämä aktivaatio tapahtuu jo ennen kuin 
influenssa B-virus alkaa monistua. Osoitimme solunsisäisen, viruksen RNA 
molekyylejä tunnistavan RIG-I-reseptorin olevan tärkeä aikaisen interferonivasteen 
käynnistymiselle. Toisessa työssä vertasimme interferonivasteita pandeemisen 
H1N1-alatyypin influenssa A-viruksen ja kausi-influenssavirusten kesken. Tutkimus 
osoitti, että pandeeminen virus laukaisi heikon sytokiinivasteen ihmisen 
immuunisoluissa, mutta solujen esikäsittely interferoneilla esti pandeemisen 
viruksen monistumista tehokkaasti. 
Soluilla on useita erilaisia reseptoreita, jotka voivat tunnistaa eri mikrobirakenteita 
infektion aikana. Yksi tämän työn tavoitteista oli tutkia Tollin kaltaisten 
reseptoreiden (TLR) yhteistoimintaa ihmisen valkosolumalleilla. Tuloksemme 
vahvistivat muiden tutkijoiden aiemmat havainnot siitä, että solujen stimulointi 
TLR3 tai TLR4 reseptorin välityksellä samanaikaisesti TLR7/8 reseptorin kanssa 
saa aikaan voimakkaan interleukiini 12 ja interferoni ?1 tuotannon. Synergian 
mekanismia selvitettäessä havaittiin, että useiden eri transkriptiotekijöiden ja 
solunsisäisten viestintäketjujen samanaikainen aktivaatio selitti voimakasta 
sytokiinituotantoa soluissa. Havaitsimme myös, että TLR3:n välityksellä tapahtunut 
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interferonituotanto lisäsi TLR7:n ja TLR7-välitteisen viestintäketjun proteiinien 
tuotantoa, mikä voi osaltaan edesauttaa viestintäketjujen aktivaatiota ja voimistaa 
sytokiinituotantoa mikrobi-infektion tai TLR-stimulaation aikana. 
Tämä väitöskirjatyö tarkastelee isäntäsolun ja taudinaiheuttajan välisiä 
vuorovaikutussuhteita ja valottaa synergistisen sytokiinituotannon mekanismeja 
ihmisen immuunisoluissa. Lisäksi tutkimus kuvaa influenssa B-virusinfektion 
aikaisia vaiheita ja pandeemisen H1N1 influenssa A-viruksen laukaisemia 
sytokiinivasteita. Tämän työn tarkoituksena on ollut osaltaan lisätä ihmisen 
luontaisen immuniteetin aktivoitumisen yksityiskohtaista tuntemusta, mikä on 
edellytys turvallisten ja tehokkaiden rokotteiden ja viruslääkkeiden kehittämiselle. 
Avainsanat: luontainen immuniteetti, influenssavirus, interferoni, sytokiini, Tollin 
kaltainen reseptori, makrofagi, dendriittisolu 
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1 Introduction 
Viruses were discovered more than 100 years ago. Since then it has become evident 
that viruses outnumber all cellular forms of life both in quantity and genetic 
diversity (Koonin and Dolja, 2013). Viruses are ancient obligate parasites that infect 
cells from all domains of life. They have greatly contributed to the evolution of 
humankind starting from the emergence of the first primordial cell (Forterre, 2006). 
Viruses are comprised of genetic material, RNA or DNA, a protein coat called a 
capsid and in some cases a host cell-derived lipid membrane, an envelope. Many 
viruses are human pathogens and thus studying the pathogenesis of viral infections 
and virus-host cell interactions is of great scientific and practical importance. On the 
other hand, the analysis of the biology of viral infections has taught us many aspects 
of cell biology. Presently, viruses are widely used as vaccines and potential gene 
therapy vectors as well as tools in biotechnology. 
 
Viruses depend on the cellular machinery to complete their life cycle and hence the 
host-pathogen interplay builds up complex networks of interactions between the 
cellular and viral proteins. Viruses have evolved sophisticated means to manage 
with a minimal number of genes and yet turn the cell into a virus copy machine to 
produce thousands of infectious particles per cell. As this is often harmful to the host, 
host cells have also developed numerous means to fight against viral infection. 
These defense mechanisms are called the immune system which includes two arms, 
innate and adaptive immunity. The innate immune response is rapidly activated and 
rather unspecific reaction against an invading pathogen. The adaptive immunity 
takes a longer time to develop, but it is highly specific because of the antigen-
specific humoral and cell-mediated immune responses. The activation of adaptive 
immunity is also able to generate immunological memory. 
 
During the years that viruses were first described, the discovery of antibodies 
(reviewed in Llewelyn et al., 1992) initiated the studies on adaptive immunity. The 
topic of this thesis, innate immunity, was introduced later and the concept of pattern 
recognition receptors being able to distinguish self from non-self was presented by 
Charles Janeway in 1989 (Janeway, 1989). The first pattern recognition receptors 
were found in the drosophila fly (Lemaitre et al., 1996) and in human (Medzhitov et 
al., 1997) and since then a plethora of different receptors have been described that 
survey the extracellular and intracellular space of the cells for the potential microbial 
and other danger signals. The sensing of danger by the cell triggers the production 
and secretion of small messenger proteins, cytokines, which are essential in the 
communication between cells and in directing the cell movement and activation. 
Highly complex cellular signaling pathways carry the information of pathogen 
Review of the literature 
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recognition into the cell nucleus to initiate gene expression aiming at the production 
of proteins needed for the defense responses against microbial pathogens. The 
research conducted during the past 20 years has immensely increased our knowledge 
on innate immune signaling pathways activated by pathogen recognition receptors. 
 
This thesis discusses the influenza virus-induced cytokine gene expression in human 
innate immune cells i.e. dendritic cells (DCs) and macrophages. The early events in 
influenza virus infection were analysed in the context of activation of cell signaling 
pathways leading to interferon (IFN) gene expression. Moreover, the activation of 
IFN induction by different influenza A virus strains was characterized. In addition, 
the cooperation of different pattern recognition receptors, namely Toll-like receptors 
(TLRs), in inducing cytokine expression was studied by analysing the cell signaling 
pathways required for the synergistic activation of cytokine gene expression. 
 
 
2 Review of the literature 
2.1 Influenza viruses 
 
Influenza viruses are respiratory pathogens that cause seasonal epidemics and 
occasionally pandemics in the human population. World Health Organization 
estimates that influenza virus infection leads to the death of 250 000 - 500 000 
humans every year, infecting 5 % - 10 % of the population (Keitel et al., 1997; 
Neuzil et al., 2002; Thompson et al., 2003; Thompson et al., 2009). During 
pandemics, a new type of influenza virus against which the human population has 
limited immunity, is able to spread from human to human, often causing significant 
morbidity. Previous influenza pandemics include the 1918 Spanish influenza, the 
1957 Asian influenza, the 1968 Hong Kong influenza, and the 2009 (A) H1N1 
swine influenza. Humankind constantly faces the fear of a new deadly influenza 
pandemic arising, as novel reassortant avian influenza viruses such as H5N1 and 
H7N9 are infecting people in the south-east Asia. 
 
Presently, it is possible to fight pandemics with vaccines, which in the most recent 
2009 H1N1 pandemics turned out to be successful. Vaccines against seasonal 
influenza are available and if the next year’s circulating viruses match the vaccine 
strains well, the vaccines give effective protection against the infection. The 
problem with influenza A viruses is that they evolve rapidly; the high error rate of 
the viral RNA polymerase causes mutations in the virus leading to antigenic drift. In 
addition, the different influenza subtypes change gene segments with each other in 
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coinfection, giving rise to new reassortant viruses in a process called antigenic shift. 
As a result, the vaccine does not confer long-lasting immunity but needs to be taken 
yearly. Other possible treatments include antiviral drugs such as amantadine, 
rimantadine and neuraminidase inhibitors. The drawback with the drugs is that 
influenza viruses have developed resistance to these and thus novel ways to control 
influenza virus infection are needed. 
 
Influenza viruses belong to the family Orthomyxoviridae and are classified into 
influenza A, B and C viruses. Wild aquatic birds are the natural host of influenza A 
viruses, but the viruses are able to infect many different mammals, including 
humans. Influenza A viruses are subtyped according to the antigenic properties of 
their surface glycoproteins; 18 different hemagglutinin (HA) and 11 neuraminidase 
(NA) types are presently known (Neumann and Kawaoka, 2015). Of these subtypes, 
H1-H16 and N1-N9 are found circulating in bird populations but only H1N1, H2N2 
and H3N2 viruses have caused annual epidemics in humans so far. The influenza 
H17N10 (Tong et al., 2012) and H18N1 (Tong et al., 2013)  viruses were recently 
discovered from bats. Influenza B viruses only infect humans and some marine 
mammals. Two distinct evolutionary lineages circulate in humans, called Victoria 
and Yamagata lineages. Influenza C viruses infect humans and pigs but are rare and 
thus less is known about them. Recently, a novel influenza virus was found in swine 
and cattle, resulting in the proposal to form a new influenza D virus genus (Collin et 
al., 2015; Sreenivasan et al., 2015). 
2.1.1 Influenza virus structure 
Influenza A and B viruses are pleomorphic enveloped viruses with a negative 
orientation single-stranded RNA (ssRNA) genome divided into eight segments. 
From these segments up to 16, or in the case of influenza B, 11 different proteins are 
encoded. The viral RNA segment forms a viral ribonucleoprotein (vRNP) complex 
(Fig.1) where nucleoprotein (NP) monomers are associated with the viral RNA and 
together form an antiparallel double helix structure (Eisfeld et al., 2015). The 5´and 
3´ends of the RNA segment are partially complementary and form a panhandle 
structure which is bound by the viral polymerase complex consisting of single PB1, 
PB2 and PA proteins. The vRNP complexes are packaged into a virus particle that 
consists of matrix protein (M1) shell that is surrounded by the host-derived lipid 
membrane. The viral glycoproteins HA and NA are embedded in the membrane, as 
well as the ion channel protein M2 (Lamb and Lai, 1981). Influenza B virus has an 
additional ion channel NB. Influenza viruses also code a minor structural protein, 
nuclear export protein (NEP) (Yasuda et al., 1993) and a nonstructural protein NS1 
that is not packaged in the viruses but is present in infected cells. NS1 is the best 
known multifunctional virulence factor of influenza virus and it is able to restrict 
IFN responses, for example (Krug, 2015). In addition, some influenza A virus 
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strains encode accessory proteins such as PB1-F2 (Chen et al., 2001; Conenello et 
al., 2007), PB1-N40 (Wise et al., 2009), PA-X (Jagger et al., 2012), PA-155, PA-
182 (Muramoto et al., 2013) and PB2-S1 (Yamayoshi et al., 2015) that have been 
shown to regulate virus-host interactions or interfere with the defense systems of the 
host. 
 
 
Figure 1. Influenza A-virus structure. (Adapted from Eisfeld et al., 2015; Wang and Palese, 
2009). Influenza virus genome segments are organized into vRNP structures where the viral RNA 
(vRNA) is associated with multiple NP proteins and a polymerase complex comprising PB1, PB2 
and PA proteins. These vRNPs are packaged in a virion that is build of M1 matrix protein, 
includes M2 ion channel proteins and nuclear export proteins (NEP) and is surrounded by a host 
cell-derived lipid envelope. Viral glycoproteins, hemagglutinin (HA) and neuraminidase (NA), are 
embedded in the lipid bilayer. 
2.1.2 Influenza virus entry and replication cycle 
Influenza viruses spread via respiratory droplets, aerosols or surfaces contaminated 
with nasal secretions. Influenza viruses infect humans via the respiratory tract where 
the virus HA binds to sialic acid residues in the cell surface receptors of the airway 
epithelial cells. In addition to sialic acids, influenza viruses may utilize other 
receptors for binding or entry such as DC-specific intercellular adhesion molecule-3-
grabbing non-integrin (DC-SIGN) (Londrigan et al., 2011; Wang et al., 2008), 
mannose binding lectins (Reading et al., 2000; Upham et al., 2010) and epidermal 
growth factor receptor (EGFR) (Eierhoff et al., 2010). Human influenza A viruses 
prefer glycoproteins with ?2,6 -linked sialic acids which are found in the human 
upper respiratory tract (Shinya et al., 2006). Avian influenza A viruses instead bind 
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and found on the surface of type II pneumocytes residing at alveolar and bronchial 
level in the human lungs (Shinya et al., 2006). It is thought that this partially 
determines the species specificity of the influenza A viruses. Influenza viruses use 
the host cell machinery for all the steps in the entry process of the virus and several 
human proteins have been shown to be essential for the infection to take place 
(Konig et al., 2010). 
 
After the adsorption of the virus particle to the cell surface, the viral particle is 
endocytosed via receptor-mediated endocytosis (Fig. 2) (Matlin et al., 1981). The 
best characterized route into the cell for influenza A virus is clathrin-mediated 
endocytosis (de Vries et al., 2011; Lakadamyali et al., 2004) but also 
macropinocytosis (de Vries et al., 2011) and clathrin- and caveolin-independent 
endocytosis (Sieczkarski and Whittaker, 2002)  have been proposed. It has been 
shown that filamentous influenza viruses prefer macropinocytosis (Rossman et al., 
2012). After the internalization of the virus, it travels via early and late endosomes 
towards the perinuclear space. The journey has been shown to involve three stages 
(Lakadamyali et al., 2003). First, an actin-dependent transport takes the endosome 
containing the virion to the cell periphery, then a dynein-directed movement is 
observed and finally a microtubule-dependent movement into the perinuclear space 
takes place. As the endosome matures, the pH decreases from 6.8-5.9 in early 
endosomes to 6.0-4.8 in late endosomes (Huotari and Helenius, 2011). The acidic 
environment induces conformational change in the HA (White and Wilson, 1987) 
and enables the fusion between the viral and endosomal membranes leading to the 
release of the nucleocapsid. The optimal pH for the fusion varies between different 
HA subtypes (Galloway et al., 2013) and the human isolates fuse in lower pH than 
the avian isolates even within the same subtype. The pH drop also opens up the viral 
M2 ion channels (Wharton et al., 1994) and the subsequent acidification of the 
virion results in the dispersion of the M1 matrix proteins (Fontana and Steven, 2013; 
Zhirnov, 1990) and vRNPs are released into the cytosol in the process called 
uncoating. Recently, the uncoating of the virion was shown to be dependent on the 
proteasome machinery of the cell (Banerjee et al., 2014). After uncoating, vRNPs 
are imported into the nucleus for viral replication and transcription to start. The 
nuclear import of the vRNPs relies on the nuclear pore complex and importin 
proteins which associate with the nuclear localization signal (NLS) of the NP 
proteins (Melen et al., 2003; O'Neill et al., 1995). 
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Figure 2. Influenza virus entry and replication cycle. (Adapted from Julkunen et al., 2001; Shi 
et al., 2014). Influenza virus binds sialic acid containing receptors of the cell and is endocytosed 
via receptor-mediated endocytosis. The acidification of the endosome prepares the virion for the 
fusion event, where the hemagglutinin facilitates the fusion between viral and endosomal 
membranes, releasing the nucleocapsid. The acidification also enables the dispersion of M1 
protein and uncoating of the vRNPs. After nuclear entry of the vRNPs, the primary transcription 
takes place to transcribe viral mRNAs which are translated into viral proteins in the cytoplasm. 
Following nuclear import of newly synthesized viral proteins, viral replication and secondary 
transcription takes place and the assembled nucleocapsids are exported to the cell cytoplasm. The 
viral proteins and vRNPs gather to the plasma membrane for the budding of the progeny virions.    
 
After the entry into the nucleus, viral polymerase proteins bound to the viral gene 
segments start the primary transcription of the viral mRNA (Jorba et al., 2009). The 
process does not require de novo protein synthesis (Mark et al., 1979), but is 
dependent on cellular mRNA synthesis; the virus steals the caps from the cellular 
pre-mRNAs to be used as primers by the viral polymerase complex in a process 
called cap-snatching (Plotch et al., 1979; Plotch et al., 1981). The primary 
transcription produces viral mRNAs which are then translated by the cellular 
ribosomes in the cytoplasm. Once newly synthesized polymerase proteins and NP 
have been transported into the nucleus, viral replication may take place (Vreede et 
al., 2004). First a full-length complementary RNA (cRNA) needs to be made to 
amplify the viral genomic vRNA, which is then assembled into progeny vRNPs. In 
the late phase of infection, the newly formed vRNPs are exported into the cytoplasm 
by cellular chromosome region maintenance protein 1 (CRM1)-dependent nuclear 
export process (Elton et al., 2001). Influenza viruses can also induce the 
enlargement of the nuclear pores that promotes the export of vRNPs (Muhlbauer et 
al., 2015). vRNPs are then transported to the plasma membrane via RAB11 
recycling endosomes and microtubule networks (Amorim et al., 2011; Eisfeld et al., 
2011; Momose et al., 2007; Momose et al., 2011). In addition to the vRNPs, the 
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viral proteins are also recruited to the plasma membrane and the budding of the 
progeny virions takes place (Noda and Kawaoka, 2010). The viral particle is 
released from the cell membrane once the NA cleaves the sialic acid residues of the 
host cell. 
2.2 Innate immunity 
 
The host defense against pathogens has been categorized into innate and adaptive 
immunity. Innate immunity is the omnipresent arm of the immunity which is 
unspecific and activated rapidly after recognition of danger. Innate immunity 
includes the physical barriers of skin and mucosa, the chemical barriers of different 
antimicrobial substances secreted on epithelial surfaces, the complement system and 
different innate immunity effector cells that are capable of recognizing and 
eliminating invading pathogens. The activation of innate immunity is a prerequisite 
for the activation of adaptive immunity which is activated rather slowly and 
comprises the immunological memory and specific antibodies against a certain 
pathogen. The antigen presenting cells of innate immunity, namely macrophages and 
DCs, are a crucial bridge between innate and adaptive immunity.  
2.2.1 Macrophages and dendritic cells 
Macrophages and DCs are mononuclear phagocytes that act as sentinels throughout 
the body. It was historically believed that both of these cell types can originate from 
a common precursor in the bone marrow and that monocytes are the link between 
the progenitor cells and tissue-resident macrophages and DCs (Mildner et al., 2013). 
It has now become increasingly evident that macrophages and DCs are a very 
versatile and heterogeneous group of cells with different origins. Just now, attempts 
are made to revise the classification of mononuclear phagocytes and unify the 
nomenclature (Guilliams et al., 2014; Guilliams and van de Laar, 2015; Tussiwand 
and Gautier, 2015; Wynn et al., 2013). 
 
Resident macrophages in different tissues such as Langerhans cells in the skin, 
microglia in the brain, Kupffer cells in the liver, osteoclasts in the bone, alveolar 
macrophages etc., have great functional diversity and important roles in tissue repair, 
homeostasis and immunity.  Many of these resident macrophages are self-renewable 
and originate from the yolk sac and/or fetal liver during embryogenesis (Gomez 
Perdiguero et al., 2015; Wynn et al., 2013). A third source of macrophages is the 
bone marrow-derived monocyte/macrophage and DC progenitor (MDP) cells that 
give rise to monocytes via common monocyte precursor (cMoP) (Hettinger et al., 
2013). Macrophages have great phagocytosing potential and are able to engulf and 
degrade pathogens as well as cell debris. Thus especially the bone marrow-
originated macrophages are able to differentiate into inflammatory macrophages, 
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also called M1 macrophages to distinguish them from deactivated M2 or healing 
macrophages (Italiani and Boraschi, 2014). Macrophages express a wide array of 
receptors aimed at recognition of pathogens discussed in the next section. Both 
alveolar and monocyte-derived macrophages express sialic acid receptors that bind 
influenza viruses (Yu et al., 2011). Whether these cell types support a productive 
influenza infection varies between different influenza strains and cell types (Short et 
al., 2012). Monocyte-derived macrophages but not alveolar macrophages are 
productively infected with seasonal influenza viruses (van Riel et al., 2011; Yu et al., 
2011). 
 
DCs originate from MDPs in the bone marrow via common DC precursor (CDP) 
(Naik et al., 2007; Onai et al., 2007) and pre-DC cells (Ginhoux et al., 2009; Liu et 
al., 2009). Pre-DCs give rise to classical DCs (cDCs), also called conventional or 
myeloid DCs (mDCs), and plasmacytoid DCs (pDCs) (Siegal et al., 1999). cDCs are 
the most important antigen presenting cells as they are highly phagocytic as 
immature cells and have a strong migratory and cytokine-producing capacity after 
maturation. cDCs that have encountered a pathogen, upregulate major 
histocompatibility complex (MHC) molecules and costimulatory receptors to 
become matured, and move to tissue-draining lymph nodes to present antigens to T 
cells. cDCs are categorized by their surface markers into cDC1 and cDC2 subtypes 
(Guilliams et al., 2014). Human cDC1 cells are blood DC antigen (BDCA) 3 
positive and mouse cDC1 cells express CD103 or CD8, whereas human cDC2 cells 
are BDCA1 (CD1c) positive and mouse cDC2 cells express CD11b or CD4 
(Guilliams et al., 2014; Mildner and Jung, 2014). These subsets are functionally 
distinct; cDC1 cells are superior in inducing Th1 type T cell responses whereas 
cDC2 cells more likely induce Th2 or Th17 T cell responses. However, based on 
surface markers, tens of different DC subtypes have been described, thus the great 
heterogeneity in the expression levels of different markers and different cell 
maturation stages complicates the definition of DC subsets. pDCs are specialized 
cells that are capable of producing high amounts of type I IFNs in response to viral 
infection (Nakano et al., 2001; Siegal et al., 1999). They are, however, less efficient 
as antigen presenting cells compared to other DC types. pDCs are found in the bone 
marrow and peripheral organs (Reizis et al., 2011). DCs are recruited to the lungs 
during influenza infection (Aldridge et al., 2009; McGill et al., 2008) and are 
essential for activation of innate immunity and subsequent T cell responses 
(Ballesteros-Tato et al., 2010; GeurtsvanKessel et al., 2008; Kim and Braciale, 
2009). Monocyte-derived DCs (moDCs) express sialic acid receptors 
(Thitithanyanont et al., 2007) and are infected with seasonal and pandemic influenza 
viruses (Bender et al., 1998; Osterlund et al., 2005; Perrone et al., 2008), but only 
infections with H5N1 viruses are productive (Perrone et al., 2008; Thitithanyanont 
et al., 2007). 
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Monocytes circulate in the blood, express chemokine and adhesion receptors and are 
recruited in high numbers into inflamed tissues upon infection (Mildner et al., 2013). 
According to present views, monocytes are not just progenitor cells circulating in 
the blood, but are effector cells of their own, capable of reacting to pathogenic 
stimuli (Mildner et al., 2013). Monocytes can differentiate into macrophage- and 
DC-like cells under many inflammatory stimuli, and these populations are different 
from tissue-resident DC or macrophage populations (Geissmann et al., 2010; Italiani 
and Boraschi, 2014; Segura et al., 2013; Wynn et al., 2013). Because a limited 
number of human cDCs or macrophages are found in blood and tissues, monocytes 
have been widely used for research as they can be differentiated into monocyte-
derived macrophages and moDCs using the growth factors colony-stimulating-factor 
(CSF)-1 (or granulocyte-macrophage (GM)-CSF) and GM-CSF + interleukin (IL)-4, 
respectively (Sallusto and Lanzavecchia, 1994). In mouse, similar cells are acquired 
from bone marrow with GM-CSF and these cells have been called bone marrow-
derived DCs (BMDCs) (Inaba et al., 1992; Lutz et al., 1999). However, a recent 
study showed that this method produces a highly heterogeneous mix of macrophages 
and DCs, in terms of both surface markers and functionality (Helft et al., 2015). 
These results have questioned the use of BMDCs as a DC model and it may be a 
similar case for moDCs and macrophages in humans. However, as monocytes 
recruited into the site of inflammation can differentiate into macrophage- and  DC-
like cells (Cheong et al., 2010; Mildner et al., 2013; Serbina et al., 2003; Zigmond et 
al., 2012) in vivo, in vitro-differentiated cells can still be a relevant model at least for 
the studies concerning host-pathogen interactions. Nevertheless it is clear that the 
mononuclear phagocyte system is very complex; the cell populations are extremely 
diverse and dynamic and responsive to the cytokine milieu in the tissue. 
2.2.2 Pathogen recognition by innate immunity 
An important duty of innate immunity is to distinguish self from non-self in order to 
respond to danger signals appropriately. How this is accomplished has been an area 
of intense research in the field of innate immunity. Human cells have a multitude of 
receptors used for surveillance of extracellular and intracellular milieu for the 
presence of foreign microbial structures. These receptors have been named pattern 
recognition receptors (PRRs), and the structures they sense are termed pathogen 
associated molecular patterns (PAMPs) or danger associated molecular patterns 
(DAMPs). Several classes of PRRs have been described: TLRs, C-type lectin 
receptors (CLRs), retinoic acid inducible gene (RIG)-I-like receptors (RLRs), 
nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and 
absent in melanoma (AIM) 2-like receptors (ALRs) (Brubaker et al., 2015). 
2.2.2.1 Toll-like receptors (TLRs) 
TLRs are germline encoded transmembrane proteins that recognize various 
microbial structures in the extracellular space and in the endosomal pathway (Kawai 
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and Akira, 2010). The ligand binding domain consists of leucine-rich repeats (LRRs) 
and the cytoplasmic Toll IL-1 receptor (TIR) domain is responsible for signaling 
(Liu et al., 2008). To date 10 functional TLRs have been described in man. Mice 
also encode for three additional TLRs numbered from TRL11 to TLR13. TLR10 is 
not functional in mouse and TLR11, TLR12 and TLR13 are lost from the human 
genome. The representative ligands and localization of each TLR are presented in 
the Table 1. The localization of PRRs is an important aspect in controlling the fine 
balance between recognizing self from foreign pathogens without inducing 
unnecessary inflammation or even autoimmunity (Perkins and Vogel, 2015). In 
addition, receptors are localized so that they recognize relevant microbial patterns; 
receptors recognizing nucleic acid structures all reside in the intracellular or 
endosomal compartments of the cell thus recognizing viruses and intracellular 
pathogens, whereas many bacterial cell wall components are recognized by cell 
surface receptors. 
 
TLR signaling is initiated when ligand binding induces TLR dimerization and the 
dimerized TIR-domains can recruit adaptor proteins (Fig. 3) (Narayanan and Park, 
2015). Five adaptor proteins associated with TLRs are known, namely myeloid 
differentiation primary-response protein 88 (MyD88) (Medzhitov et al., 1998), TIR-
domain-containing adaptor protein inducing IFN-???TRIF) (Yamamoto et al., 2002) 
also known as TIR-domain-containing molecule 1 (TICAM1) (Oshiumi et al., 2003), 
MyD88 adaptor-like protein (MAL) (Fitzgerald et al., 2001) also known as TIR-
domain-containing adaptor protein (TIRAP), TRIF-related adaptor molecule 
(TRAM) (Fitzgerald et al., 2003b) and inhibitory ???????? ?? ???? ???????????????
motif containing protein (SARM) (O'Neill et al., 2003). The differential adaptor 
protein usage by different TLRs (see Table 1. and Fig. 1) leads to differential 
downstream activation events. TLRs that use TRIF adaptor, namely TLR3 and 
TLR4, induce both type I IFN and inflammatory cytokine responses whereas the cell 
surface TLRs employing MyD88 induce mainly inflammatory cytokines. 
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Figure 3. TLR signaling pathways. (Adapted from O'Neill et al., 2013). TLRs are 
transmembrane proteins expressed on the plasma membrane or in the endosomal membranes. 
TLRs recognize various microbe-derived ligands of which some prototypic ligands are indicated in 
the figure. The cytosolic domains of the receptors are associated with different adaptor proteins 
(MyD88, MAL, TRIF, TRAM) that are activated upon ligand binding. The activation triggers 
complex cellular signaling pathways leading to the activation of downstream kinases (IRAKs, 
TRAFs, MAPKs, IKKs) via different phosphorylation and ubiquitinylation events. These signaling 
pathways result in the activation of transcription factors such as IRFs, NF-??? ?????????? ????
Jun/Fos that are imported to the nucleus to bind their respective promoter elements in the cytokine 
genes thus inducing cytokine gene expression. 
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Table 1. Toll-like receptors.  
TLR Localization 
(cell type) 
Ligand Origin of  
ligand 
Adaptor Reference 
TLR1/2 cell surface 
(monocytes, 
macrophages 
DCs, B cells) 
Triacyl 
lipopeptides 
Bacteria MyD88, 
MAL 
(Ozinsky et al., 
2000; 
Takeuchi et 
al., 2002) 
TLR2/6  cell surface 
(monocytes, 
macrophages, 
mast cells, DCs, 
B cells) 
Diacylated 
lipoprotein 
Peptidoglycan 
Lipoteichoic acid 
Zymosan 
Various 
pathogens 
Gram+ bacteria 
 
Fungi 
MyD88, 
MAL 
(Kang et al., 
2009; Ozinsky 
et al., 2000) 
TLR3  Endosome (B-
cells, T cells, 
natural killer 
cells, DCs) 
Cell surface 
(fibroblasts) 
dsRNA Viruses TRIF (Alexopoulou 
et al., 2001) 
TLR4 Cell surface 
(monocytes, 
macrophages, 
DCs, mast cells, 
intestinal 
epithelium) 
LPS 
 
Fusion protein 
 
 
Envelope protein 
 
Gram- bacteria 
 
Respiratory 
syncytial virus 
 
Mouse 
mammary-tumor 
virus 
MyD88, 
MAL, 
TRIF, 
TRAM 
(Kurt-Jones et 
al., 2000; 
Medzhitov et 
al., 1997; 
Poltorak et al., 
1998; Rassa et 
al., 2002) 
TLR5 Cell surface 
(monocytes, 
macrophages, 
DCs, intestinal 
epithelium) 
Flagellin Bacteria MyD88 (Hayashi et al., 
2001; Smith et 
al., 2003) 
TLR7 Endosome 
(monocytes, 
macrophages, 
DCs, B cells) 
Imidazoquinoline 
Loxoribine 
ssRNA 
 
Synthetic 
Synthetic 
Viruses, bacteria 
 
MyD88 (Heil et al., 
2003; Heil et 
al., 2004; 
Hemmi et al., 
2002; 
Mancuso et 
al., 2009) 
TLR8 Endosome 
(monocytes, 
macrophages, 
DCs, mast cells) 
Imidazoquinoline 
ssRNA 
Synthetic 
Viruses, bacteria 
MyD88 (Eberle et al., 
2009; Heil et 
al., 2004; Jurk 
et al., 2002) 
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TLR9 Endosome 
(monocytes, 
macrophages, 
DCs, B cells, T 
cells) 
Unmethylated CpG 
DNA 
Bacteria, viruses MyD88 (Hemmi et al., 
2000) 
TLR10 Endosome? 
(monocytes, 
macrophages 
DCs, B cells, T 
cells) 
unknown Listeria 
monocytogenes 
Influenza virus 
MyD88 (Chuang and 
Ulevitch, 
2001; Lee et 
al., 2014; 
Regan et al., 
2013) 
TLR11* Endosome 
(macrophages, 
DCs, kidney and 
bladder 
epithelial cells) 
Profilin-like 
proteins 
Uropathogenic 
bacteria 
Toxoplasma 
gondii 
MyD88 (Yarovinsky et 
al., 2005; 
Zhang et al., 
2004) 
TLR12* Endosome 
(macrophages, 
DCs, B cells, T 
cells) 
Profilin Toxoplasma 
gondii 
MyD88 (Koblansky et 
al., 2013) 
TLR13* Endosome 
(macrophage, 
DCs) 
23S rRNA Bacteria MyD88 (Li and Chen, 
2012; 
Oldenburg et 
al., 2012) 
(Adapted from Akira and Takeda, 2004; Narayanan and Park, 2015). 
* TLR11, TLR12 and TLR13 have only been found in the mouse and they are absent in the human 
system. 
 
2.2.2.2 RIG-I-like receptors (RLRs) 
RLRs are cytoplasmic sensors of RNA viruses expressed by nearly all cell types 
(Chan and Gack, 2015; Kell and Gale, 2015; Yoneyama et al., 2004; Yoneyama et 
al., 2015). RLR family comprises three RNA helicases: RIG-I, melanoma 
differentiation-associated gene 5 (MDA5) and laboratory of genetics and physiology 
2 (LGP2). RLRs bind RNA structures with the DExD/H-box domain and C-terminal 
domain (CTD) whereas signaling takes place via N-terminal caspase activation and 
recruitment domains (CARDs). As LGP2 lacks these signaling domains, it is 
thought to act as a regulator of RIG-I and MDA5 signaling (Komuro and Horvath, 
2006; Rothenfusser et al., 2005; Saito et al., 2007; Satoh et al., 2010). The optimal 
ligand for RIG-I is believed to be short (<300 bp) dsRNA or panhandle RNA with 5´ 
triphosphate moiety (Baum et al., 2010; Hornung et al., 2006; Pichlmair et al., 2006; 
Schlee et al., 2009), although RIG-I has been shown to interact with RNA of various 
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lengths and end modifications (Goubau et al., 2014). MDA5, instead recognizes 
longer (>2000 bp) dsRNA molecules (Feng et al., 2012; Kato et al., 2008) and no 
known specific RNA modifications are needed for the recognition. RLRs have been 
shown to recognize many different types of RNA viruses (Errett et al., 2013; Gitlin 
et al., 2010; Kato et al., 2006; Loo et al., 2008) and are thus essential in inducing an 
antiviral state in response to virus infection. 
2.2.2.3 Other pattern recognition receptors (PRRs) 
NLRs are a large family of cytosolic receptors inducing inflammation, autophagy 
and cell death (Barbe et al., 2014). They comprise three functional domains: an N-
terminal domain for signal transduction, a central domain for oligomerization and a 
C-terminal LRR domain for ligand binding. Upon activation NLRs form large 
protein complexes and especially the LRR- and pyrin domain-containing protein 
(NLRP) subgroup receptors scaffold into multiprotein complexes termed 
inflammasomes (Martinon et al., 2002). The inflammasome activates caspases, 
proteases that are important mediators of apoptosis and necrosis. The activation of 
caspase-1 leads to the proteolytic cleavage of proIL-????????????-18, secretion of 
mature IL-?????????-18, and subsequently to a special type of cell death, pyroptosis 
(Bergsbaken et al., 2009). NLRs recognize a vast array of bacterial ligands and host 
cell-derived danger-associated molecules (Schroder and Tschopp, 2010). NLR 
called nucleotide oligomerization and binding domain (NOD2) receptor also has a 
role in viral infections (Lupfer et al., 2014; Sabbah et al., 2009). 
 
ALRs are the most recently established class of PRRs and they act as cytosolic DNA 
sensors (Paludan and Bowie, 2013). The founding member AIM2 (Fernandes-
Alnemri et al., 2009; Hornung et al., 2009; Roberts et al., 2009) recognizes dsDNA, 
activates the inflammasome and induces IL-?????????-18 production. In addition to 
ALRs, several putative cytosolic DNA sensors have been described (Unterholzner, 
2013). The primary DNA sensing receptor in the cytosol is cyclic GMP-AMP 
synthase (cGAS) (Li et al., 2013; Sun et al., 2013) and its activation leads to IFN 
expression via adaptor protein stimulator of IFN genes (STING) (Ishikawa and 
Barber, 2008; Ishikawa et al., 2009; Sun et al., 2009; Zhong et al., 2008). STING is 
also a receptor for cyclic dinucleotides that are bacterial second messenger 
molecules (Burdette et al., 2011). Normally, DNA is contained in the nucleus but 
can be found in the cytosol as a result of microbial infection, aberrant host DNA 
metabolism or uptake of apoptotic cellular debris. 
 
CLRs are best known for their role in anti-fungal immunity and they recognize 
????????????????????????-glucan, which is present in the fungal cell wall (Dambuza 
and Brown, 2015). The most studied CLR is DC-associated C-type lectin (Dectin)-1 
(Brown and Gordon, 2001) which has a role in phagocytosis, autophagy, respiratory 
burst and production of inflammatory lipids, cytokines, chemokines and IFNs 
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(Dambuza and Brown, 2015). In addition to anti-fungal immunity, CLRs take part in 
recognition of dead cells, tumors and bacteria, especially mycobacteria. It is 
suggested, that they also regulate homeostasis, autoimmunity and allergy. 
2.2.3 Cytokines 
Cytokines are pleiotropic signaling molecules that are vital in cell communication. 
They facilitate many different immunity-related functions, such as cell 
differentiation, cell trafficking, antigen presentation and immune cell activation. 
Cytokines act in an autocrine or paracrine fashion via receptors recognizing 
cytokines in the same or in a neighboring cell, respectively. In some instances, 
cytokines may have systemic effects. Many different cell types secrete cytokines and 
express cytokine receptors on the cell surface. Cytokines include interferons (IFNs), 
interleukins (ILs), chemokines, growth factors, tumor necrosis factor (TNF) family 
members and adipokines. Two features define cytokines: pleiotropy, meaning that 
one cytokine elicits diverse functionality and redundancy, meaning that different 
cytokines exert overlapping activities (Ozaki and Leonard, 2002). Cytokine 
responses can be synergistic if two simultaneous signals induce a stronger cytokine 
response than two individual stimulators. One signal can also act antagonistically by 
reducing the cytokine response induced by another signal. 
 
IL-12 is a heterodimeric proinflammatory cytokine that comprises p35 and p40 
subunits and signals via IL-12 receptor which is composed of IL-????? and IL-
?????? ???????? (Presky et al., 1996). IL-12 signaling leads to the activation of 
Janus-activated kinase 2 (JAK2) and tyrosine kinase 2 (TYK2) which phosphorylate 
transcription factors signal transducer and activator of transcription 1 (STAT1), 
STAT3, STAT4 and STAT5 (Trinchieri, 2003). IL-12 produced by DCs and 
macrophages promotes the differentiation of naïve CD4 T cells into T helper 1 (Th1) 
cells (Macatonia et al., 1995; Manetti et al., 1993), linking the innate and adaptive 
immunity. Many microbial products induce the expression of IL-12p35 and IL-
12p40 subunits which both are needed to produce bioactive IL-12p70 (Goriely et al., 
2008). IL-12p35 expression is tightly controlled and it is a limiting factor in IL-
12p70 production whereas IL-12p40 is secreted in excess over IL-12p35 and also as 
a homodimer (Goriely et al., 2008). Several studies have reported a synergistic IL-
12 production in response to TLR stimulation via different TLRs (Bohnenkamp et 
al., 2007; Gautier et al., 2005; Napolitani et al., 2005). Such synergism offers a way 
to control proinflammatory cytokine production; only when multiple TLRs or other 
PRRs are triggered, high amounts of cytokines are produced. 
2.2.4 Interferons 
IFN was the first cytokine described in 1957 as it was found to interfere with the 
influenza virus infection (Isaacs and Lindenmann, 1957). Since then a great deal of 
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research into the importance of IFNs has been carried out and three classes of IFNs 
have been described. Type I IFNs include 13 different functional subtypes of IFN-??
and IFN-??????-??????-?????????-??????-?????????????????ber of type II IFNs and 
type III IFNs consists of IFN-???????-???????-??????????-?? (McNab et al., 2015; 
Prokunina-Olsson et al., 2013). IFNs induce the expression of hundreds of IFN-
stimulated genes (ISGs) that are essential in inducing an antiviral state in IFN-
stimulated cells. In addition to IFNs’ direct antiviral effects, IFNs regulate many 
important aspects in innate immunity against viral infection such as the expression 
of PRRs, apoptosis, cytokine production, cell differentiation, polarization and 
proliferation. 
 
The receptor that binds type I IFNs is composed of IFNAR1 and IFNAR2 chains 
(Domanski and Colamonici, 1996; Novick et al., 1994) that are ubiquitously 
expressed in tissues. Similarly, IFN-???????????????????????????????????? (Pestka 
et al., 1997), which is broadly expressed. The type III IFN receptor is expressed 
mainly in epithelial cells and consists of IFNLR1 and IL10R2 (Kotenko et al., 2003; 
Sheppard et al., 2003).  The effects of IFNs are mediated via JAK1 and TYK2, 
whose interaction leads to the phosphorylation of STAT1 and STAT2 proteins. 
STAT1 and STAT2 form a dimer that recruits IFN regulatory factor 9 (IRF9) to 
make up the IFN-stimulated gene factor 3 (ISGF3) complex that can bind the 
promoter regions of ISG (Darnell et al., 1994; Qureshi et al., 1995). 
 
Type I and III IFNs are expressed once the cells sense the presence of a pathogen 
with their PRRs. Both bacterial and viral ligands are able to induce type I and III 
IFN responses and the two types of IFNs share the transcription factors needed for 
their gene expression (Decker et al., 2005; Osterlund et al., 2005; Osterlund et al., 
2007; Pietila et al., 2010). Type I IFNs induce DC maturation, enhance antigen 
presentation and increase the ability of DCs to prime T cells (Ito et al., 2001; Le Bon 
et al., 2003; Montoya et al., 2002). Type I IFNs have many effects on T cell 
proliferation, survival and effector cell differentiation (Havenar-Daughton et al., 
2006; Kolumam et al., 2005; Le Bon et al., 2006; Marshall et al., 2010). The 
outcome, however, seems to depend on the timing of IFNAR and T cell receptor 
activation which determines which STAT proteins are activated (Crouse et al., 2015). 
IFN-???share many biological functions with type I IFNs; although, as the receptor 
of IFN-? is expressed mainly in epithelial cells, the antiviral actions of IFN-???????
vary depending on the site of infection (Iversen and Paludan, 2010). 
2.2.5 Signaling pathways controlling cytokine gene expression 
The activation of innate immunity is controlled tightly, because an immune response 
improperly adjusted may have a detrimental impact on the host. Cytokine production 
is mainly regulated on the transcriptional level by several transcription factor 
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families that bind to their respective promoter elements in the cytokine genes. The 
well-known signaling cascades leading to cytokine gene expression are the IRF, 
nuclear factor of ? light polypeptide gene enhancer in B-cells (NF-??) and mitogen-
activated protein kinase (MAPK)-pathways. 
 
The MyD88 adaptor-dependent pathway is activated by all TLRs except TLR3. 
Upon TLR activation, MyD88 interacts with IL-1 receptor-associated kinase 1 
(IRAK1), IRAK2 and IRAK4 forming a macromolecular complex where IRAK4 
can phosphorylate IRAK1 and IRAK2 (Fig. 3) (Kawagoe et al., 2008; Lin et al., 
2010; Motshwene et al., 2009). TNF receptor-associated factor 6 (TRAF6) is then 
activated, K63-polyubiquitinated (Deng et al., 2000) and binds TAK1-binding 
protein 1 (TAB1), TAB2 and TAB3 which leads to transforming growth factor-?-
activated kinase 1 (TAK1) recruitment and activation. TAK1 can phosphorylate 
inhibitor of NF-?B kinase ? (????), which then phosphorylates inhibitor of NF-?B 
? (????) (Wang et al., 2001). The proteasomal degradation following K48-
??????????????????? ??? ????? leads to the release of NF-??? ??????????? ???????????
which can then translocate to the nucleus to activate genes bearing NF-?? binding 
sites. TAK1 can also activate MAPK kinase 4/7 (MKK4/7), MKK3/6 (Wang et al., 
2001) and MKK1/2, which can activate Jun N-terminal kinase (JNK), p38 MAPK 
and extracellular signal-regulated kinase (ERK) 1 and ERK2, respectively. The 
MAPK signaling cascades eventually activate activating protein (AP)-1 transcription 
factor composed of dimers formed by Jun, Fos or activating transcription factor 
(ATF) subunits. The activation of NF-??? ???? ??-1 leads to the production of 
cytokines such as IL-12, IL-6 and TNF-?? 
 
TLR3 and TLR4 use the TRIF adaptor protein to activate a MyD88-independent 
pathway (Fitzgerald et al., 2003b). TRIF is able to activate NF-??? ???? ?????
pathways via TRAF6 or TRAF6/RIP1 leading to the activation of downstream 
kinases as in the MyD88-dependent pathway (Fig. 3). The TRIF pathway also leads 
to the activation of an important transcription factor IRF3, which induces IFN gene 
expression. This happens through the activation of TRAF3, which K63-ubiquitinates 
TANK-binding kinase 1 (TBK1) ???? ??B kinase ?? (IKK?), which subsequently 
phosphorylate IRF3 (Fitzgerald et al., 2003a; Hacker et al., 2006; Hemmi et al., 
2004; McWhirter et al., 2004). The phosphorylated IRF3 forms dimers that 
translocate into the nucleus to bind IFN-stimulated response element (ISRE) sites in 
IFN gene promoters (Lin et al., 1998). 
 
The cytoplasmic RLRs signal via CARD domains that interact with the CARD of 
the mitochondrial antiviral-signaling protein (MAVS) adaptor protein (Fig. 4), also 
known as IPS-1, VISA or Cardif (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 
2005; Xu et al., 2005). In steady state, the CARD domains of RIG-I are folded over 
one another to block signaling (Kowalinski et al., 2011). Upon biding of its RNA 
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ligands RIG-I undergoes an ATP-dependent conformational change rendering the 
CARD domains available for signaling. CARDs are then dephosphorylated (Wies et 
al., 2013) and CTD is ubiquitinylated by Riplet (Oshiumi et al., 2013). Tripartite 
motif-containing protein 25 (TRIM25) ubiquitin ligase adds ubiquitin to the CARDs 
in RIG-I which leads to RIG-I oligomerization and MAVS binding (Gack et al., 
2007; Jiang et al., 2012)  in the mitochondrial associated membrane (MAM). As a 
result, ???????????????????????????, leading to the activation of IRF3 and NF-???
(Seth et al., 2005; Xu et al., 2005) which are translocated into the nucleus to drive 
the gene expression of IFNs and pro-inflammatory cytokine genes. RIG-I regulation 
has been studied extensively and many levels of regulation have been described 
(Chan and Gack, 2015; Errett and Gale, 2015; Kell and Gale, 2015), such as post-
transcriptional mechanisms including alternative splicing of RIG-I (Gack et al., 2008) 
or MAVS mRNA (Brubaker et al., 2014; Lad et al., 2008) and microRNA-mediated 
negative feedback regulation of signaling pathway components (Hou et al., 2009). 
MDA5 signals similarly via MAVS and ????????? but the details are still unclear.  
2.2.5.1 IRFs 
Currently, nine proteins are known in the mammalian IRF family of transcription 
factors (Ikushima et al., 2013). The most important transcription factors in RLR 
signaling and TRIF-dependent signaling regulating IFN gene expression are IRF3 
and IRF7. IRF3 is constitutively expressed (Au et al., 1995). TBK1-mediated 
phosphorylation of the serine residues in the auto-inhibitory region of IRF3 allows it 
to dimerize and translocate into the nucleus (Fitzgerald et al., 2003a; Lin et al., 
1998). IRF7 expression level, on the other hand, is low in most cells but strongly 
inducible with type I IFNs. IRF7 thus contributes to the positive feedback loop of 
IFN signaling (Sato et al., 2000a). IRF7 also undergoes a phosphorylation event in 
order to be imported into the nucleus (Marie et al., 2000). Moreover, IRF3 and IRF7 
can form heterodimers that bind ISRE sites in the gene promoters (Au et al., 2001). 
In pDCs, which express IRF7 constitutively, MyD88-dependent signaling also leads 
to IRF7 activation via TLR7 and TLR9 (Honda et al., 2005a; Honda et al., 2005b; 
Kerkmann et al., 2003). 
 
The first IRF discovered was IRF1 which is involved in IL-12 gene expression in 
cooperation with IRF8 (Liu et al., 2003; Liu et al., 2004; Maruyama et al., 2003; 
Masumi et al., 2002). The role of IRF8 in the development of mononuclear cells has 
been extensively studied (Tamura et al., 2015). In addition, IRF8 regulates IFN 
response as IRF8 is needed for the late phase IFN gene expression in mouse DCs 
(Tailor et al., 2007). Recently, IRF8 was shown to cooperate with STAT1 in 
inducing the activation of many IFN-?-activated genes (Mancino et al., 2015). 
Several studies have indicated that IRF5 is important in IFN induction (Barnes et al., 
2001; Barnes et al., 2003; Lazear et al., 2013; Schoenemeyer et al., 2005; Yanai et 
al., 2007). IRF5 also takes part in the induction of proinflammatory cytokine genes 
Review of the literature 
 
35 
 
via MyD88-dependent signaling pathway (Takaoka et al., 2005). IRF4 can compete 
with IRF5 in binding MyD88 (Negishi et al., 2005) and is thus considered a negative 
regulator of TLR signaling. IRF9 is best known as a subunit of ISGF3, which it 
forms together with STAT1 and STAT2.  
2.2.5.2 NF-?B 
The NF-????????????????????????????????????????of subunits p65 (RelA), RelB, c-Rel, 
p50 (NF-???? and p52 (NF-???) which form hetero- or homodimers (Brady and 
Bowie, 2014). The inhibitory ???????????????????????????????????????????????????-
??????????s and the activation of NF-???????????????????????? ??????????????? the 
proteasome. PRR ligands or proinflammatory cytokines activate the classical 
(canonical) NF-?? pathway where the IKK complex phosphorylates p65 ???????? 
(Zandi et al., 1997) ???????? ??? ???????????? ??? ????? ???? ???????? ???p65 or c-Rel -
containing dimers. The alternative (non-canonical) NF-??????????? ??? ??????????by 
TNF family members other than TNF-?, ???????????????-mediated phosphorylation 
of p100, the precursor for p52 (Senftleben et al., 2001). Proteolytic maturation of 
p52 allows it to form a dimer with RelB and to translocate into the nucleus. The 
maturation of p105 into p50 takes place constitutively (Fan and Maniatis, 1991). 
2.2.5.3 MAP kinases 
The MAPK signaling cascade comprises many sequentially activated kinases; a 
MAPK kinase kinase activates MAPK kinase (MKK), which then phosphorylates 
MAPK (Arthur and Ley, 2013). In mammalian cells 14 different MAPKs are known: 
six ERK-, four p38- and three JNK-family proteins and one NEMO-like protein 
kinase (NLK). At present, kinases downstream of MAPKs have also been described. 
The MAPK pathway is very complex and its different branches have both pro-
inflammatory and anti-inflammatory (negative regulation) functions in immunity. 
Often MAPK-regulated pathways are cell type specific. 
2.3 Influenza virus and the host 
 
Influenza viruses enter the host via the respiratory tract and are first encountered by 
the mucus covering the epithelium. The primary target cells of influenza viruses are 
epithelial cells in the respiratory tract. In addition, influenza viruses infect immune 
cells, such as macrophages and DCs, which reside underneath the epithelial layer. 
IFNs (Cella et al., 1999; Ronni et al., 1995), proinflammatory cytokines (Chan et al., 
2005) and chemokines (Matikainen et al., 2000; Veckman et al., 2006) are produced 
by these cells in response to the infection, and both local and systemic inflammatory 
responses are activated. Chemokines produced by epithelial cells and immune cells 
recruit neutrophils, monocytes and natural killer (NK) cells to the infection site to 
phagocytose and destroy virus-infected cells (Herold et al., 2006; Perrone et al., 
2008). Antigen presenting cells take up viral antigens and migrate to the lymph 
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nodes to present them to T cells, thus inducing the activation of adaptive immunity 
against influenza. 
 
The outcome of the influenza virus infection in the host depends on many factors. 
On the host side underlying diseases, age, pregnancy, host genetic background and 
previous influenza infections affect the severity of the infection. On the other hand, 
some influenza strains are more virulent than others and the case fatality rate of 
influenza viruses differs from less than 0.1 % up to 60 %. The reasons for this are 
largely unknown, but for example virulence factors, properties of the viral 
polymerase or glycoproteins and host specificity of the virus may play a role. 
2.3.1 Innate immune recognition of influenza virus 
RLRs play a crucial role in RNA virus recognition as mice deficient in this pathway 
are highly susceptible to infections with various RNA viruses (Kato et al., 2006). 
RIG-I, which is expressed by nearly all cell types, is the most important receptor 
inducing IFN gene expression during influenza virus infection (Fig. 4). Viruses have 
developed many means to counteract RIG-I which imply that it must be a central 
player in the innate immunity against viruses. It has been proposed that in vitro 
transcribed (Hornung et al., 2006)  and influenza virus replication-derived 
(Pichlmair et al., 2006) 5´-triphosphate ssRNAs are ligands for RIG-I. However, it is 
now thought that a short stretch of dsRNA is essential for RIG-I recognition (Schlee 
et al., 2009) and such a dsRNA structure, termed a panhandle is present in the 
influenza virus vRNPs due to complementarity of 5´ and 3´ termini of the influenza 
virus genome segments. Recently, it has been shown that RIG-I readily recognizes 
the panhandle structure present in the incoming virus (Weber et al., 2015). In 
addition, 5´-triphosphate bearing defective interfering particles generated during 
influenza infection are efficient ligands for RIG-I (Baum et al., 2010; Tapia et al., 
2013). Influenza virus activates caspase-1 and caspase-3 which leads to the secretion 
of IL-18 (Pirhonen et al., 1999; Pirhonen et al., 2001; Rintahaka et al., 2008) via 
RIG-I, and in primary lung epithelial cells RIG-I is the key factor inducing IL-???
(Pothlichet et al., 2013) thus giving rise to a term RIG-I-inflammasome (Chen and 
Ichinohe, 2015). 
 
Studies using mouse embryonic fibroblasts (MEFs) deficient in MDA5 protein have 
shown that MDA5 receptor is dispensable for influenza-induced IFN responses 
(Kato et al., 2006; Loo et al., 2008). In contrast, chicken cells which lack RIG-I 
(Barber et al., 2010; Zou et al., 2009), can sense avian influenza viruses with MDA5 
receptor (Liniger et al., 2012). A recent report using an in vivo RNAi screening 
revealed a contributing role for MDA5 in the in vivo response to influenza A virus 
lacking NS1 (Benitez et al., 2015); MDA5 was important in amplifying the host 
antiviral response even though it did not contribute to type I IFN induction. In 
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addition, a biased acute inflammatory response in the lungs of MDA5 deficient mice 
has been observed (Kim et al., 2014). The influenza virus-specific ligands that are 
recognized by MDA5 are not known as it is thought that dsRNA is not generated 
during negative sense ssRNA virus replication (Weber et al., 2006). 
 
 
Figure 4. Virus-induced signaling pathways. (Adapted from Jiang et al., 2015). RNA viruses are 
recognized by endosomal PRRs TLR3 and TLR7/8 which bind dsRNA and ssRNA, respectively. 
For more detailed TLR signaling see Fig. 3. The cytosolic RNA receptors include RIG-I which is 
triggered by 5´phosphate containing dsRNA and MDA5 which binds longer dsRNA molecules. 
The receptors activate the downstream kinases (IKKs, TBK1) via adaptor proteins (MyD88, TRIF, 
MAVS) leading to the phosphorylation and activation of IRF- and NF-??-family transcription 
factors. The transcription factors are subsequently imported into the nucleus and bind the promoter 
elements in the cytokine genes to induce gene expression. 
 
Endosomal TLR7 and TLR8 recognize ssRNA structures and are potent PRRs in the 
recognition of influenza virus. However, during a successful influenza virus entry, 
virions are likely remaining intact in the endosomal compartments and thus 
inaccessible for TLR ligand binding. If some viruses are not able to escape the 
endosomal pathway before lysosomal degradation, TLR recognition may happen. It 
is possible that NP and polymerase proteins always associated with the ssRNA 
genome of influenza, interfere with TLR ligand binding. During phagocytosis of 
influenza-infected cells, pDCs have been shown to recognize the ssRNA genome of 
NF-??
p50 p65
P
IRF3
ISRE
P
IRF3
P
IRF3
ISRE
P
IRF7
P Cytokine genes
Nucleus
dsRNA
Endosome
Plasma membrane
Mitochondrion
ssRNA
IKK? TBK1
RIG-I
IRF3
P
MDA5
I??? P
p50 p65
PIRF3
P
IRF7
P
IRF7
P
IRF7 IRF3
P P
RIG-ITRIM25
5´phosphate 
dsRNA
Virus
IKK?
IKK? IKK?
long dsRNA
Riplet
Ub
IKKs
Review of the literature 
 
38 
 
the virus via TLR7 (Diebold et al., 2004; Lund et al., 2004). In addition, TLR7 and 
pDCs are essential for whole inactivated influenza virus vaccine-induced cytotoxic 
T lymphocyte (CTL) responses (Budimir et al., 2013). Much of the knowledge on 
TLR recognition has been acquired from knock-out mouse studies. It was earlier 
believed that TLR8 is not functional in mice and thus the function of TLR8 in 
influenza virus recognition is still unclear. TLR3 recognizes dsRNA, which is not 
generated during influenza virus infection, because of the helicase UAP56 
(Wisskirchen et al., 2011). TLR3 deficient mice sustain higher viral loads and 
reduced leukocyte infiltrations in the lungs which indicate that TLR3 does, however 
play a role in influenza recognition (Le Goffic et al., 2006). Intriguingly, although 
its ligand is still unknown, TLR10 was involved in influenza virus-induced innate 
immune responses in human macrophages (Lee et al., 2014).  
 
Several studies have demonstrated the importance of NLR protein NLRP3 in 
influenza infection (Allen et al., 2009; Ichinohe et al., 2009; Thomas et al., 2009). 
NLRP3-inflammasome activation led to caspase-1 activation and IL-??????????????
in influenza virus-infected cells. Viral RNA (Thomas et al., 2009), the nonstructural 
protein PB1-F2 (McAuley et al., 2013) and M2 ion channel protein (Ichinohe et al., 
2010) are involved in NLRP3-inflammasome activation. A recent paper suggested 
that another NLR protein NLRC5 played a role in influenza infection by cooperating 
with RIG-I receptor (Ranjan et al., 2015) to induce IFN-?. It is not known whether 
NLRC5 is able to bind any influenza virus-specific ligands. 
2.3.2 Influenza virus-induced cell signaling 
Influenza virus triggers multiple signaling pathways during the course of infection. 
Some of these pathways are antiviral, some virus-supportive or even both depending 
on the step of infection and the time of activation. Phosphatidylinositol-3-kinase 
(PI3K) signaling has been shown to regulate influenza virus entry (Ehrhardt et al., 
2006). PI3K is a kinase that phosphorylates membrane phospholipids and it 
regulates cell metabolism, proliferation and survival (Neri et al., 2002). The 
activation of PI3K leads to the activation of a downstream effector protein Akt 
(Vanhaesebroeck et al., 2012). Influenza A NS1 is able to activate PI3K to prevent 
apoptosis (Ehrhardt et al., 2007b; Hale et al., 2006) and thus enable efficient virus 
replication. It has also been shown that PI3K takes part in the RIG-I- and IRF3-
mediated signaling pathway that induces type I IFN responses in influenza virus-
infected cells (Hrincius et al., 2011). 
 
Autophagy is a mode of “self-eating” targeted to harmful proteins or pathogenic 
protein aggregates in the cytosol. Only lately it has been recognized that viruses can 
take advantage of the autophagy machinery (Dreux and Chisari, 2010). Influenza A 
virus induces autophagosome formation (Zhou et al., 2009) and NS1, HA (Zhirnov 
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and Klenk, 2013) and especially M2 proteins (Gannage et al., 2009) are involved in 
the regulation of autophagy. In the study by Gannage and coworkers M2 protein was 
shown to prevent the autophagosome fusion with lysosome resulting in 
autophagosome accumulation in the cells. It has been postulated that by regulating 
autophagy, influenza virus can evade the host immune response as the autophagic 
cell death results in lower immunogenicity of the virus (Zhang et al., 2014). 
 
Autophagy is connected with another cellular event induced by influenza, a 
programmed cell death, apoptosis (Zhang et al., 2014). It seems that autophagy can 
inhibit apoptosis, as in the autophagy-deficient cells, influenza A virus-induced 
apoptotic cell death was increased (Gannage et al., 2009). Influenza virus is known 
to downregulate apoptosis in an NS1-dependent way (Jackson et al., 2010; Zhirnov 
et al., 2002), but whether this depends on the PI3K-Akt pathway (Ehrhardt et al., 
2007a; Hale et al., 2006) or not (Jackson et al., 2010) is contradictory. PI3K plays a 
role both in autophagy and apoptosis (Zhang et al., 2014) hence more research into 
this topic is needed to create a complete picture. 
 
The roles of PRRs RIG-I, MDA5, TLR3 and TLR7/8 in influenza virus recognition 
are discussed in Section 2.3.1 and the cytokine signaling pathways downstream of 
these receptors in Section 2.2.5 (see also Fig. 4). In addition to inducing cytokine 
production, some of these pathways have been indicated to take part in other aspects 
of influenza virus-host crosstalk. MAPK pathway Raf/MKK/ERK is needed for the 
nuclear export of influenza vRNP complexes (Marjuki et al., 2006)  and blocking 
this pathway reduces influenza propagation (Pleschka et al., 2001). Another 
signaling pathway affecting influenza virus growth is the NF-??-pathway 
(Nimmerjahn et al., 2004; Wurzer et al., 2004) for which multiple molecular 
mechanisms have been described (Ludwig, 2009). 
2.3.3 Antiviral responses against influenza virus 
The major soluble mediators of antiviral responses are IFNs, whose action is largely 
conveyed by the antiviral proteins encoded by the ISGs. These factors are often 
ready-made in the cell and restrict virus entry, replication or assembly by directly 
interacting with the virus. The fist ISG found to constrain influenza virus infection 
was the myxovirus resistance gene Mx (Staeheli et al., 1986). The mouse proteins 
are called Mx1 and Mx2 of which only Mx1 blocks influenza infection (Haller et al., 
2009). The human counterparts, MxA and MxB are IFN-inducible and MxA inhibits 
influenza A infection (Turan et al., 2004; Xiao et al., 2013). MxA has been shown to 
interact with NP (Turan et al., 2004) and inhibit viral replication (Pavlovic et al., 
1992). MxA can also block influenza A infection at the level of incoming virus by 
preventing the nuclear localization of viral vRNPs (Xiao et al., 2013). 
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Another important protein restricting influenza virus infection is an IFN-inducible 
transmembrane protein 3 (IFITM3) (Brass et al., 2009). IFITM3 blocks influenza 
virus entry at late endosomal stage by interfering with the formation of a fusion pore 
between the viral and endosomal membrane (Desai et al., 2014). It has been 
suggested that patients with severe influenza infection are more likely to have a 
genetic defect in IFITM3 gene (Everitt et al., 2012; Zhang et al., 2013) but opposing 
data exist (Mills et al., 2014). Nevertheless, mice lacking IFITM3 are highly 
susceptible to influenza viruses (Bailey et al., 2012). 
 
Additional antiviral proteins against influenza virus are the 2´-5´-oligoadenylate 
synthase (OAS) and ribonuclease L (RNAseL) that cooperate to cleave viral ssRNA 
(Silverman, 2007). Other known antiviral proteins with numerous functions are 
protein kinase R (PKR), IFN-induced protein with tetratricopeptide repeats (IFIT)-
proteins, viperin, thetherin, TRIM22 and ISG15 (Iwasaki and Pillai, 2014; Pulendran 
and Maddur, 2015). A novel influenza virus restriction mechanism is virus 
inhibition by host cell-derived microRNAs (miRNA). At least miR136, miR323, 
miR491, miR654 and let-7c have been shown to interfere with influenza A virus 
replication (Ma et al., 2012; Song et al., 2010; Zhao et al., 2015).  
2.3.4 Viral countermeasures against host 
As viruses and the host cells have evolved hand in hand, viruses have developed 
means to counteract the antiviral defense of the host. In the case of influenza, NS1 
protein has been a horn of plenty in regard to its functions for inhibiting the cellular 
defense against influenza virus. NS1 is a small 26 kDa protein with an RNA binding 
domain and an effector domain (Krug, 2015). It is not present in the virion and the 
virus is able to replicate in the absence of it. NS1 protein sequences between 
influenza A viruses are very conserved, however there are major functional 
differences between different virus strains (Kochs et al., 2007; Kuo et al., 2010). 
NS1 interferes with IFN gene expression by inhibiting IRF3 (Talon et al., 2000), 
NF-??? (Wang et al., 2000) and AP-1 (Ludwig et al., 2002) activation but the 
mechanisms are yet obscure. NS1 has been shown to bind many factors in the RIG-I 
pathway: RIG-I itself (Guo et al., 2007; Mibayashi et al., 2007; Opitz et al., 2007), 
TRIM25 (Gack et al., 2009) and Riplet (Rajsbaum et al., 2012). A long known 
feature of the influenza NS1 is its capability to inhibit the cellular mRNA production. 
This happens via NS1 binding of the cleavage and polyadenylation specificity factor 
(CPSF30) (Nemeroff et al., 1998) which interferes with the 3´end formation of pre-
mRNAs. Influenza NS1 also binds and inhibits antiviral proteins produced by the 
cell, PKR (Li et al., 2006; Min et al., 2007) and OAS (Min and Krug, 2006). As 
discussed earlier, NS1 has been shown to regulate host cell apoptosis by interacting 
with PI3K. 
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An additional influenza A virus-encoded virulence factor is PB1-F2 (Chen et al., 
2001), which induces apoptosis and inhibits type I IFN induction (Varga et al., 
2011). It contributes to the virulence of several pandemic viruses such as the 1918 
H1N1, the 1957 H2N2 and the 1968 H3N2, and the highly pathogenic avian 
influenza (HPAI) H5N1 viruses (Conenello et al., 2007; McAuley et al., 2010). 
However, the 2009 pandemic H1N1 virus does not encode PB1-F2 (Ozawa et al., 
2011). From PB1 mRNA a second polypeptide is synthesized named PB1-40 (Wise 
et al., 2009) but the significance of the variant protein in the context of virus fitness 
is not known. Another polymerase protein-derived virulence factor is PA-X (Jagger 
et al., 2012) which has a role in shut-off of cellular gene expression (Hayashi et al., 
2015). Recently two other proteins translated from influenza A virus PA mRNA 
were described (Muramoto et al., 2013) and termed PA-N155 and PA-N182. They 
may have functions in the replication cycle of the virus as viruses lacking PA-N155 
and PA-N182 replicated more slowly. A very recent study found a splicing variant 
also for the polymerase subunit PB2, PB2-S1, which was able to inhibit RIG-I-
dependent IFN pathway (Yamayoshi et al., 2015). It is probable that even more viral 
proteins encoded by spliced mRNAs will be found in the near future thus explaining 
in part the diversity of influenza virus-induced responses in the cell and strain-
specific features of influenza viruses. 
 
In recent years it has become evident that innate immune responses are also 
regulated by the expression of non-protein-coding RNAs such as miRNAs. 
Interestingly, it was shown in 2014 that long noncoding RNA (lncRNA) is important 
in successful influenza A virus infection (Winterling et al., 2014). IFNs have been 
shown to induce the expression of specific lncRNAs which were also induced by 
NS1 deficient influenza A virus, but not with wt influenza A virus (Carnero et al., 
2014). Moreover, NS1 has been shown to induce the expression of vault RNA 
(vtRNA) (Li et al., 2015), which is another type of noncoding RNA. The expression 
of vtRNA interferes with PKR activity leading to enhanced virus replication (Li et 
al., 2015).  
Aims of the study 
 
42 
 
3 Aims of the study 
Innate immune cells such as macrophages and DCs express various pattern 
recognition receptors that are employed for the recognition of microbial pathogens, 
including influenza viruses. The sensing of pathogen structures triggers the 
activation of intracellular signaling cascades leading to the production of cytokines 
and antiviral IFNs. During infection, several different pathogen-derived molecules 
are present that can activate different pattern recognition receptors in a cooperative 
manner to induce additive or synergistic production of cytokines. In this study the 
mechanisms of synergistic IL and IFN expression induced by different TLR ligands 
were studied. Another research aim was to analyze the induction of IFNs by 
different influenza viruses in human macrophages and DCs. 
 
The specific aims of this study were: 
 
? To study the early events of influenza B virus infection and influenza B 
virus-induced IFN responses in human macrophages (I). 
? To characterize IFN induction by the novel 2009 pandemic H1N1 
influenza virus in human macrophages and DCs (II). 
? To elucidate the synergistic mechanisms of IL-12 cytokine gene 
expression induced by different TLRs (III). 
? To analyze the synergy between RNA-recognizing TLRs in inducing 
IFN-????????????????????????????DCs (IV). 
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4 Materials and methods 
4.1 Ethics statement 
 
Adult human blood was obtained from anonymous healthy blood donors from the 
Finnish Red Cross Blood Transfusion Service (permission renewed yearly). Animal 
immunizations related to this study were approved by the Ethical Committee of 
National Institute for Health and Welfare (permission KTL 2008-02). 
4.2 Cell culture 
4.2.1 Differentiation of macrophages and DCs from peripheral blood-
derived monocytes (I, II, III, IV) 
Human peripheral blood mononuclear cells (PBMC) were purified from freshly 
collected, leukocyte-rich buffy coats obtained from healthy blood donors (Finnish 
Red Cross Blood Transfusion Service, Helsinki). The cells were isolated by density 
gradient centrifugation over a Ficoll-Paque gradient (Amersham Biosciences) 
(Veckman et al., 2004). To obtain monocytes for macrophage differentiation, 
mononuclear cells were allowed to adhere to plates for 1 h at +37°C in RPMI-1640 
(Sigma-Aldrich) supplemented with 0.6 ?g/ml penicillin, 60 ?g/ml streptomycin, 2 
mM L-glutamine, and 20 mM HEPES. Non-adherent cells were removed by 
washing with cold PBS and remaining monocytes were cultured in 
macrophage/serum-free medium (Life Technologies) supplemented with antibiotics 
and human rGM-CSF, 10 ng/ml (Nordic Biosite). The cells were differentiated into 
macrophages for 7 days changing fresh culture media every 2 days. 
 
To obtain moDCs, Ficoll-Paque gradient centrifugation was followed by Percoll 
gradient (Amersham Biosciences) centrifugation (Veckman et al., 2004). The top 
layer containing monocytes was collected, and the remaining T and B cells were 
depleted using anti-CD3 and anti-CD19 magnetic beads (Dynal). Monocytes were 
allowed to adhere to plates for 1 hour at +37°C in RPMI-1640 supplemented as 
above. Adhered monocytes were washed with PBS and immature DCs were 
generated by cultivating cells in RPMI-1640 medium supplemented with 10 % FCS 
(Integro), 10 ng/ml human rGM-CSF, 20 ng/ml human rIL-4 (R&D Systems) and 
antibiotics. The cells were cultivated for 6 days and fresh media was added every 2 
days. 
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4.2.2 Mouse embryonic fibroblast cells (I) 
Primary wild type (wt) and Irf3-/-Irf7-/- mouse embryonic fibroblasts (MEFs) and 
Rela-/-Rel-/-?f???-/- (NF-?? knock-out) MEF cell line were kindly provided by Dr. A. 
Hoffmann, Signaling Systems Lab, Los Angeles. Primary wt (Rig-I+/+), Rig-I-/-, 
Mda5-/- and Rig-I-/-Mda5-/- MEFs were obtained from mouse embryos and they were 
immortalized by rigorous passaging protocol to obtain wt and knock-out cell lines. 
The MEF cell lines were cultured in DMEM-medium supplemented with 0.6 μg/ml 
penicillin, 60 μg/ml streptomycin, 2 mM L-glutamine, 20 mM HEPES and 10 % 
FCS. 
4.3 Viruses and infection experiments (I, II) 
 
Viruses used in the study are listed in the Table 2. All viruses were grown from a  
10-5 dilution of stock virus in allantoic cavities of 11-day-old embryonated chicken 
eggs at +34°C for 3 days. Influenza stock virus titers were determined by a plaque 
assay on MDCK cells (Osterlund et al., 2012) or the infectivity of the virus stocks in 
human DCs and macrophages was determined by analyzing the percentages of 
virus-infected cells with flow cytometry (II) or immunofluorescence (I). The 
propagation of the A/Finland/553/2009 virus stock and the infection experiments 
with this virus were carried out under BSL-3 conditions at that time. The infection 
experiments are described in more detail in the materials and methods sections of 
the original publications (I, II). 
Table 2. Viruses used in the study 
Virus Type HA titer PFU/ml  Used in 
A/Finland/553/2009 H1N1 16   II 
A/Brisbane/59/07  H1N1 128  II 
A/NewCaledonia/20/99  H1N1 256  II 
A/WSN/33 H1N1 128  II 
A/Udorn/72 H3N2 256  II 
A/Beijing/353/89 H3N2 128 6x107 (MDCK) I 
B/Shangdong/7/97  64 18x107 (MDCK) I 
Sendai virus Cantell strain  6x109 (moDC) I 
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4.4 Reagents 
4.4.1 Antibodies and cytokines 
The antibodies used in the study for different applications or for the neutralization of 
IFN during experiments are defined in the Table 3. IFNs used for priming the cells 
or for studying the IFN sensitivity of influenza viruses and cytokines used for moDC 
and macrophage differentiation are listed in the Table 4. 
Table 3. Antibodies 
Antibody Application Source/reference Used in 
Guinea pig anti-IRF1 WB (Matikainen et al., 1996) III, IV 
Rabbit anti-p-IRF3 (ser396) WB #4947 Cell Signaling Technology I, IV 
Rabbit anti-IRF3 WB #4302 Cell Signaling Technology I 
Rabbit anti-IRF3 WB, IF (Osterlund et al., 2005) I, III, IV 
Rabbit anti-IRF4 WB sc-28696 Santa Cruz III 
Rabbit anti-IRF5 WB (Pietila et al., 2007) III 
Guinea pig anti-IRF7 WB (Osterlund et al., 2005) III, IV 
Goat anti-IRF8 WB sc-6058X Santa Cruz III, IV 
Rabbit anti-IRF9 WB sc-496 Santa Cruz III 
Rabbit anti-STAT1 WB sc-346 Santa Cruz III 
Rabbit anti-STAT2 WB sc-839X Santa Cruz III 
Rabbit anti-p50 WB sc-7178 Santa Cruz III 
Rabbit anti-p65 WB sc-372 Santa Cruz III 
Rabbit anti-???? WB #9242 Cell Signaling Technology I 
Rabbit anti-p-p38 WB #9211 Cell Signaling Technology III 
Rabbit anti-p38 WB #9212 Cell Signaling Technology III 
Mouse anti-p-p44/p42 WB #9106 Cell Signaling Technology III 
Rabbit anti-p44/p42 WB #9102 Cell Signaling Technology III 
Rabbit anti-p-Akt WB #9271 Cell Signaling Technology III 
Rabbit anti-Akt WB #9272 Cell Signaling Technology III 
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Rabbit anti-p-c-Jun WB #9261 Cell Signaling Technology III 
Rabbit anti-IFITM3 WB AP1153a Abgent I 
Rabbit anti-MxA FC, WB (Ronni et al., 1993) I, II 
Rabbit anti-actin WB sc-10731 Santa Cruz I 
Mouse anti-nucleolin WB sc-8031 Santa Cruz III 
Rabbit anti-GAPDH WB #2118 Cell Signaling Technology I 
Mouse anti-EEA1 IF 610456, BD Biosciences I 
Mouse anti-LAMP1 IF sc-20011, Santa Cruz I 
Guinea pig anti-NP IBV IF  I 
Rabbit anti-NP IBV WB (Osterlund et al., 2012) I 
Rabbit anti-NS1 IBV WB (Osterlund et al., 2012) I 
Guinea pig anti-NP IAV IF  I 
Rabbit anti-NP IAV WB (Osterlund et al., 2012) I 
Rabbit anti-NS1 IAV WB (Osterlund et al., 2012) I 
Rabbit anti-GP H1N1 FC (Julkunen et al., 1983) II 
Sheep anti-IFN-??????-? IFN- 
neutralization 
(Mogensen et al., 1975) IV 
WB,Western blotting; IF, immunofluorescence; FC, flow cytometry; GP, glycoprotein. 
Table 4. Purified cytokines 
Cytokine Concentration used Source/reference Used in 
Recombinant IFN-?? 1, 10, 100 IU/ml Schering-Plough II 
Recombinant IFN-? 1, 10, 100 IU/ml Schering-Plough II, IV 
Recombinant IFN-?? 10 ng/ml ZymoGenetics IV 
Recombinant IFN-?? 1, 10, 100 ng/ml (Dellgren et al., 2009) II 
Recombinant IFN-?? 1, 10, 100 ng/ml (Dellgren et al., 2009) II 
Human recombinant GM-
CSF 
10 ng/ml Nordic Biosite I- IV 
Human recombinant IL-4 20 ng/ml R&D Systems I-IV 
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4.4.2 TLR ligands 
TLR ligands used in the study are summarized in the Table 5.  
Table 5. TLR ligands used in the study 
TLR Ligand Description Concentration 
used 
Source/reference Used 
in 
TLR1/2 Pam3CSK4 a synthetic 
tripalmitoylated 
lipopeptide 
100 ng/ml InvivoGen III 
TLR3 PolyI:C Polyinosic-polycytidylic 
acid, mimics dsRNA 
???????? Sigma-Aldrich III, IV 
TLR4 LPS Lipopolysaccharide from 
Escherichia coli serotype 
O111:B4 
100 ng/ml Sigma-Aldrich I, III, 
IV 
TLR5 Flagellin Flagellin from 
Salmonella enterica sv. 
Typhimurium 
500 ng/ml InvivoGen III 
TLR7/8 R848 imidazoquinoline 
compound 
5-????? Alexis Biochemicals III, IV 
4.4.3 Pharmacological inhibitors 
Inhibitors used in the study and their cellular targets are summarized in the Table 6. 
Table 6. Pharmacological inhibitors 
Inhibitor Concentration 
used 
Cellular target Source/reference Used 
in 
Bafilomycin A1 
(BafA1) 
10 nM vacuolar H+ ATPase Sigma-Aldrich I 
Cycloheximide (CHX) ???????? de novo protein 
synthesis 
Sigma-Aldrich I, IV 
Dynasore ????? dynamin Sigma-Aldrich I 
Ly294002 ????? PI3K Calbiochem III, IV 
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PDTC ?????? NF-?? Alexis 
Biochemicals 
III, IV 
PD98059 ????? MEK1 Calbiochem III, IV 
SB202190 5-????? p38 Alexis 
Biochemicals 
III, IV 
SP600125 ????? JNK Alexis 
Biochemicals 
III, IV 
4.5 Quantitative real time PCR (qRT-PCR) 
 
Total cellular RNA was isolated from MEFs, moDCs or macrophages derived from 
??????????????????????????????????????????????????????????????? ????????????????
of total cellular RNA was reverse transcribed into cDNA in TaqMan RT buffer with 
5.5 mM MgCl2?? ???? ??? ??????? ???? ??? ?????? ??????? ??? ??????? ?????????? ????
????? ?????? ?????????? ???? ????? ????? ???????????? ???????? ?????????????? ?????????
Biosystems). cDNA samples were then amplified in TaqMan universal PCR master 
mix buffer (Applied Biosystems) with Gene Expression system assay mix 
oligonucleotides (Applied Biosystems) shown in the Table 7 to analyze mRNA 
levels. Each cDNA sample was amplified in duplicate or triplicate with Stratagene 
Mx3500P (Agilent Technologies). The mRNA levels were normalized against 
human 18S rRNA (I, II), mouse GAPD ???? ??? ?-actin (III, IV) mRNA and the 
amounts of the studied mRNA relative to unstimulated cells were calculated with 
?????–method. 
Table 7. qRT-PCR gene expression assays 
Gene Assay ID Source/reference Used in 
IFN-??? Hs00256882_s1 Applied Biosystems II, IV 
IFN-?? Hs00277188_s1 Applied Biosystems I, II, IV 
IFN-?????????? Mm00439552_s1 Applied Biosystems I 
IFN-??? Hs00601677_g1 Applied Biosystems I, II, IV 
IFN-??/3 Hs00820125_g1 Applied Biosystems II, 
TNF-? Hs00174128_m1 Applied Biosystems I, II 
TNF-????????? Mm00443260_g1 Applied Biosystems I 
IL-6  Hs00174131_m1 Applied Biosystems III, IV 
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IL-10  Hs00174086_m1 Applied Biosystems III 
IL-12p35  Hs00168405_m1 Applied Biosystems III 
IL-12p40  Hs00233688_m1 Applied Biosystems III, IV 
IL-23p19  Hs00372324_m1 Applied Biosystems III 
IL-27p28  Hs 00377366_m1 Applied Biosystems III 
IL-27 EBI3 Hs00194957_m1 Applied Biosystems III 
CXCL10  Hs00171042_m1 Applied Biosystems I, II, IV 
CXCL10 (mouse) Mm00445235_m1 Applied Biosystems I 
Mx1  Hs00182073_m1 Applied Biosystems II, IV  
IFITM3 Hs01922752_s1 Applied Biosystems I 
IRF7  Hs00242190_g Applied Biosystems IV 
TLR3  Hs00152933_m1 Applied Biosystems IV 
TLR4  Hs01061963_m1 Applied Biosystems IV 
TLR7  Hs00152971_m1 Applied Biosystems IV 
TLR8  Hs00607866_mh Applied Biosystems IV 
RIG-I  Hs00225561_m1 Applied Biosystems I 
?-actin  Hs99999903_m1 Applied Biosystems III, IV 
18S 4308329 Applied Biosystems I, II 
GAPDH (mouse) 4352339E Applied Biosystems I 
IAV M1  (Ward et al., 2004) II 
IAV NP  (Osterlund et al., 2012) I 
IBV NP  (Osterlund et al., 2012) I 
IAV NS1  (Osterlund et al., 2012) I 
IBV NS1  (Osterlund et al., 2012) I 
4.6 ELISA (II, III, IV) 
 
Cytokine levels for IL-1?, IL-6, IL-10, IL-12p70 and TNF-? from cell culture 
supernatants were analysed by fluorescent bead immunoassay using FlowCytomix 
Human Th1/Th2 10-plex kit (Bender Medsystems). IL-12p70 levels were 
determined by Elipair kit (Biosite) and by IL-23 ELISA (Bender Medsystems). 
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CCL19, CCL20 and IFN-??? were measured with a Duoset kit ELISA (R&D 
Systems), IFN-??????IFN-??????????s from PBL Biomedical Laboratories and TNF-??
and CXCL10 by using Ab pairs and standards from BD Pharmingen (San Diego, 
CA).  
4.7 Oligonucleotide precipitation assay (DNA affinity binding) 
(III, IV) 
 
TLR ligand-induced activation of transcription factors was studied by 
oligonucleotide DNA affinity binding method (Osterlund et al., 2005) using ISRE, 
mutated ISRE and NF-?B binding site-specific oligonucleotide sequences from the 
IL-12p35 promoter,  and ISRE binding site-specific oligonucleotide sequences from 
the IFN-????????????(Osterlund et al., 2007). Equal amounts of cells were harvested 
and nuclear extracts were prepared. The forward oligonucleotide was 5´–
biotinylated and a BamHI site was added as a spacer. The oligonucleotides used 
were IL-12p35 ISRE wt (5´-
GGATCCAGTAACTGCGAACATTTCGCTTTCATTTTGGGCCGAGCTGGAGG
CGGCGGGG), IL-12p35 ISRE mutant (5´-
GGATCCAGTAACTGCGACCACTGCGCGTGCAGGTCGGGCCGAGCTGGA
GGCGGCGGGG; mutations in bold), IL-12p35 NF-?B (5´-
GGATCCAAGAGACCAGAGTCCCGGGAAAGTCCTGCCGCGCCT) and IFN-
??? ????? ???-GATTTCAGTTTCTCTTTCCTTCTTGA) sites from DNA 
Technology A/S. Oligonucleotides were incubated at +4°C for 2 hours with 
streptavidin-agarose beads (Pierce). The unbound oligonucleotide was washed after 
which the protein lysates were incubated with the agarose-bound oligonucleotides at 
+4°C for 2 hours followed by washing of the unbound proteins. Oligonucleotide-
bound proteins were released in SDS sample buffer followed by Western blotting 
using specific antibodies. 
4.8 Western blot analysis (I, III, IV) 
 
Oligonucleotide binding assay samples or aliquots of whole cell lysates were 
separated on 10 % or 12 % SDS-PAGE using the Laemmli buffer system. Whole 
cell lysates were prepared by lysing cells in TN buffer containing 25 % ethylene 
glycol, passive lysis buffer from Promega or RIPA buffer all with 0.5 mM DTT, 1 
mM Na3VO4, and Complete protease inhibitor mixture. Proteins were 
electrotransferred onto Immobilon-P membranes (Millipore) or Hybond-P 
polyvinylidene difluoride (PVDF) membranes (Amersham Biosciences) which were 
blocked with 5 % milk in PBS (or in TBS for Cell Signaling antibodies) and stained 
with specific antibodies listed in the Table 3. HRP-conjugated secondary antibodies 
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(DakoCytomation) were used and proteins were visualized on HyperMax films 
using an ECL plus system (GE Healthcare). 
4.9 Immunofluorescence microscopy (I) 
 
Macrophages were differentiated on glass coverslips and infected with influenza 
viruses at a multiplicity of infection (MOI) of 30, incubated on ice for 1 hour, after 
which the virus inoculum was removed and replaced with warm media to allow 
virus entry to the cells at 37°C 5 % CO2. After indicated times the cells were fixed 
with 3 % paraformaldehyde at room temperature for 20 min, washed with PBS,  
permeabilized with 0.1% Triton X-100 for 5 min, washed and blocked with 0.5% 
BSA in PBS for 30 min. The cells were stained for 45 min in PBS containing 0.5% 
BSA at 37°C with primary antibodies listed in the Table 3. Secondary antibodies 
were FITC-labelled goat anti-guinea pig, Rhodamine Red-X-labelled goat anti-
rabbit and Rhodamine-labelled goat anti-mouse (Jackson ImmunoResearch 
Laboratories). The coverslips were washed with PBS containing 0.05% Tween 20, 
then with distilled water, and mounted in 25 % Mowiol (Polysciences) in 25 mM 
Tris-HCl, pH 7.5, 50 % glycerol, and 2.5 % 1,4-diazabicyclo[2.2.2.]octane. The 
cells were visualized under a Leica TCS SPE confocal microscope with 63x NA 
1.40 oil objective with 1 Airy unit pinhole maintaining the same image acquisition 
settings for all acquired images. The cells in the infectivity experiments were 
analyzed with a Zeiss Stallion fluorescence microscope with a Hamamatsu ORCA-
Flash 4.0 LT sCMOS camera and a 20x 0.4 NA objective by using Slidebook 6 
software. 
4.10 Flow cytometric analysis (II) 
 
Flow cytometry was used to analyze the purity of monocyte-derived macrophages 
and DCs, and the infectivity of influenza viruses in moDCs and macrophages. The 
cell samples for the flow cytometry analysis were prepared as described previously 
(Veckman et al., 2004). The cells obtained from different blood donors were 
separately infected and pooled after virus infections followed by fixation with 4 % 
paraformaldehyde for 15 min at RT. In addition, the cells used for intracellular MxA 
analysis were permeabilized with 0.1 % Triton X-100 for 5 min at RT. The 
expression of viral glycoproteins on the cell surface and MxA was measured using 
cross-reactive anti-influenza A virus H1N1 glycoprotein-specific antibodies or anti-
human MxA antibodies listed in the Table 3 and secondary FITC-labelled anti-rabbit 
antibodies (Caltag Laboratories). The cells were analyzed with FACSCanto II flow 
cytometer using FACSDiva software (Becton Dickinson). The purity of DC and 
macrophage populations were confirmed by staining noninfected cells with 
phycoerythrin (PE)-anti-CD2, PE-Cy7-anti-CD14 (Becton Dickinson), FITC-anti-
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CD80, PE-anti-CD83, allophycocyanin (APC)-anti-CD86 (Caltag Laboratories) and 
APC-H7-anti-HLA-DR antibodies (Becton Dickinson). 
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5 Results and discussion 
5.1 Human monocyte-derived macrophages and dendritic 
cells as a cell model to study innate immune responses 
 
Throughout this study, our cell model has been human blood-derived CD14+ 
monocytes differentiated into cells resembling DCs and macrophages with the help 
of growth factors. This is a well-established method (Sallusto and Lanzavecchia, 
1994) of acquiring a large number of relatively homogenous cells cost-effectively, 
as only small amounts of different human DC subtypes and macrophages are found 
in the blood. During the differentiation process, many genes are upregulated or 
downregulated differentially between monocyte-derived macrophages and DCs 
(Lehtonen et al., 2007). However, genome-wide gene expression profiling has 
shown that human in vitro-differentiated moDCs and monocyte derived 
macrophages cluster closer together than moDCs and blood BDCA3+ DCs, BDCA1+ 
DCs or pDCs (Robbins et al., 2008).  Demonstrating that the monocyte-derived cells 
are a relevant cell model in the human system, an inflammatory DC population was 
described that resembled in vitro moDCs and was likely derived from monocyte 
population (Segura et al., 2013). In addition, in steady state, a monocyte-derived 
macrophage population was recently described in the human skin (McGovern et al., 
2014). In vivo, monocyte-derived effector cells infiltrate into infection sites, 
recognize pathogens and produce cytokines in response to infection in concert with 
epithelial cells, tissue resident immune cells and different dendritic cell subtypes 
(reviewed in Schlitzer et al., 2015). Instead of using monocultures for infection 
studies, cocultures of epithelial cells and immune cells could be used as it is known 
that interactions between the different cell types affect the outcome of the immune 
response (Duell et al., 2011; Qu et al., 2003). 
5.2 Activation of innate immune responses by influenza 
viruses 
5.2.1 Influenza virus recognition by the host cell (I) 
The evolution of the virus and the host is a continuous game of hide and seek. The 
recognition of the pathogen is the first event that needs to take place in order to 
induce a proper immune response. The virus tries to avoid the recognition by the 
host cell or manipulate the subsequent signaling pathways for its own benefit. Our 
group had shown before that there is a clear kinetic difference in the IFN responses 
induced by influenza A and B viruses in human moDCs (Osterlund et al., 2012). 
Influenza B virus induced IRF3-dependent IFN-???nd IFN-?1 gene expression very 
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early upon entry, before replication of the virus, as evidenced by experiments with 
UV-treated virus. However, UV-treated and thus replication incompetent influenza 
A virus did not induce IFN. This indicated that already the incoming influenza B 
virus particles were sensed by moDCs whereas influenza A virus was able to evade 
the early recognition or interfered with the pathways leading to IRF3 activation and 
IFN gene expression. Most likely viral NS1 did not play a role in the difference 
between the viruses as it is not expressed during the first hours of infection. 
Österlund and coworkers also showed that both influenza A and B NS1 proteins 
were able to inhibit IFN-?1 gene expression to the same extent in promoter 
luciferase assay (Osterlund et al., 2012). 
 
We wanted to study the difference between influenza A and B viruses further and 
concentrated on influenza B virus, which is far less studied than influenza A. We 
wanted to know at which point of the entry influenza B virus activates IRF3 and 
which PRR is responsible for detecting influenza B virus. One possible approach 
was to use immunofluorescence microscopy. However, moDCs were not a good cell 
model for immunofluorescence since the cells are semiadherent. Macrophages 
instead are highly adherent cells and also a biologically relevant cell model as they 
reside under the epithelial cell layer in the influenza virus infection sites and are 
infected by influenza viruses. At first we confirmed, that also in human 
macrophages influenza A and B viruses induce kinetically different IFN gene 
expression patterns (Fig.1 in I). Likewise in moDCs, also in macrophages influenza 
B virus induced the activation, i.e. the phosphorylation of IRF3 already at 1 to 2 
hours, whereas in influenza A virus-infected cells, the IRF3 activation took place at 
later time points of 4 to 8 hours (Fig. 2 in I). 
 
To visualize the virus at the time when IRF3 was activated we differentiated 
macrophages on coverslips for immunofluorescence assay, infected the cells on ice 
for a synchronized infection (Martin and Helenius, 1991) and fixed cells at different 
time points up to three hours post infection in 37 °C. Confocal microscope images 
showed that at the zero time point influenza B virus NP was seen at the plasma 
membrane (Fig. 3A and Fig. 5 upper left panels in I), at 15 minutes inside the cell in 
granules and at 45-60 min time points NP started to accumulate into the nucleus. 
The kinetics of nuclear translocation of IRF3 indicated that its activation coincided 
with the influenza B virus nuclear entry. In influenza A virus-infected macrophages 
no IRF3 nuclear translocation was seen before 3 hours of infection (Fig. 3B in I). 
 
The kinetics of influenza A virus entry has been studied with high content imaging 
(Banerjee et al., 2013) where the nuclear import of influenza A virus occurred after 
one hour post infection and peaked at 3.5 hours in A549 cells. Other studies have 
shown that influenza A virus enters the nucleus at 1 hour post infection (HeLa cells) 
(Sieczkarski and Whittaker, 2003), 35 min post infection (CHO-cells) (Martin and 
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Helenius, 1991)  or even at 20 minutes post infection (MDCK-cells) (Chou et al., 
2013). The discrepancy in the kinetics is partly dependent on the host cell type used 
(Lakadamyali et al., 2004) and likely also the amount of virus stocks and the used 
antibody reagents. The entry kinetics of influenza B virus in macrophages has not 
been studied before. In macrophages influenza B virus seemed to enter the nucleus 
somewhat faster than influenza A (Fig. 3B in I) but the kinetics did not explain the 
apparent difference in IRF3 activation. 
 
To further elucidate at which step of the entry process influenza B virus activates 
IRF3 we took advantage of known inhibitors of cellular processes that are involved 
in influenza virus entry. BafA1 is an inhibitor of vacuolar H+ type ATPase and it 
prevents the acidification of the endosome which is a prerequisite for the fusion to 
happen between viral and endosomal membranes. CHX blocks protein synthesis by 
inhibiting translational elongation. Influenza virus requires newly synthetized viral 
proteins for the replication of its genome and thus CHX arrests viral replication. 
IRF3 activation and nuclear accumulation of viral NP did not take place in BafA1- 
treated and influenza B virus-infected macrophages (Fig.5 lower panels, in I). 
However, CHX-treatment did not affect influenza B-virus induced IRF3 activation. 
This means that viral replication is not needed for the IRF3 activation but most 
likely the virus needs to escape the endosomal compartment. In the presence of 
CHX, the primary transcription can still take place by the viral RNA polymerases in 
the incoming vRNPs. Thus our results do not confirm, whether viral mRNA 
transcription is needed for IRF3 activation. However, previous results from 
infections with UV-treated influenza B virus that induces robust IFN responses 
(Osterlund et al., 2012) suggest that it is the incoming vRNP structures that trigger 
IRF3 activation. 
 
A recent study using inhibitors, such as CHX, actinomycin D and  ?-amanitin to 
block viral primary transcription and 5,6-dichloro-1-?-D-ribofuranosyl-
benzimidazole to block viral RNA export from the nucleus, showed that the primary 
transcription and nuclear export are essential for the influenza A virus-induced IFN 
responses (Killip et al., 2014). As readout they used IFR3 phosphorylation in A549 
cells at eight hour time point. In our experimental setup, at eight hour time point the 
influenza B-virus induced IRF3 phosphorylation had already declined whereas 
influenza A virus induced maximal IRF3 activation at that time point (Fig. 2 in I). In 
addition in the study describing the IRF3 activation by the incoming nucleocapsids 
of influenza A (Weber et al., 2015), IRF3 was activated at one hour time point. It 
may be that in the case of influenza A viruses, RIG-I can recognize the incoming 
viral nucleocapsids but the subsequent signaling pathways are not activated because 
the viral polymerase itself can prevent the activation of RIG-I signaling pathway 
(Liedmann et al., 2014). Liedmann and coworkers found a motif in PB1 and PA 
polymerase proteins that was linked to virus-induced early activation of IRF3. The 
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authors showed that the IFN antagonism by the polymerase proteins depended on 
the interactions between the viral polymerase complex and RIG-I. Why this 
mechanism seems to inhibit the IFN activation by the incoming virus but not the 
RIG-I recognition and subsequent IFN response after virus replication is not yet 
known. This may be due to the idea discussed by Killip and coworkers that some 
presently unidentified viral transcription products are responsible for RIG-I 
activation after viral entry has taken place (Killip et al., 2014). Human H3N2 
influenza strain A/Beijing/353/89 used in this thesis does not carry the complete 
motif in PB1 and PA needed for IFN antagonism but other such adaptations may be 
found in influenza virus polymerase proteins. 
 
Macrophages are a good model to study innate immune recognition of pathogens as 
they readily express a wide array of different PRRs. The relevant receptors that bind 
influenza virus-derived ligands leading to IFN signaling are the cytosolic receptor 
RIG-I which senses 5´triphosphate ssRNA with a short dsRNA panhandle structure 
and endosomal TLR7 and TLR8 that recognize ssRNA. MDA5 and TLR3 clearly 
have some role in influenza virus infection (see Section 2.3.1.) although influenza 
virus is not expected to express dsRNA molecules during its replication (Weber et 
al., 2006; Wisskirchen et al., 2011). Since these PRRs are dispensable in influenza 
virus infection, they are not discussed here. Human macrophages express TLR8 
whereas the expression of TLR3 and TLR7 is low. However, TLR3 and TLR7 are 
induced in influenza infection via type I IFN (Miettinen et al., 2001). The incoming 
influenza B virus could be recognized via TLR7/8 in the endosomal compartments 
after endocytosis. Yet, viral ssRNA is likely protected by the viral envelope and M1 
protein and thus perhaps not accessible for TLR recognition. The viral particle 
should be first degraded in the lysosomal compartment by the host cell 
enzymes/proteases. As BafA1 also prevents the acidification of lysosomes, it would 
prevent the TLR7/8-induced IFN activation in influenza virus-infected cells. 
Moreover, the endosomal trafficking and acidification-dependent cleavage is needed 
for the functionality of endosomal TLRs (Lee and Barton, 2014). Regardless, 
TLR7/8 employs the adaptor protein MyD88 and its signaling does not lead to direct 
activation of IRF3 (Fig. 3). This excludes TLR7/8 as a putative receptor inducing 
early IFN gene expression in influenza B virus-infected macrophages. 
 
Proteins in pimary macrophages are hard to knock down and we were not successful 
in inhibiting RIG-I protein expression with small interfering RNAs (siRNAs). 
Therefore we used MEFs lacking RIG-I, MDA5 or both receptors to study whether 
RIG-I is the receptor responsible for the early IFN induction by influenza B virus. 
MEFs have been reported to express TLRs from 1 to 9 (Kurt-Jones et al., 2004). We 
generated immortalized cell lines from the primary fibroblasts by rigorous passaging 
method. The kinetic difference between influenza A and B viruses in inducing IRF3 
activation was clearly present in wt mouse fibroblasts (Fig. 4B in I) where influenza 
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B virus induced IRF3 phosphorylation at 3 hour time point and influenza A at 8 hour 
time point. As expected, RIG-I was the dominant receptor inducing IFN responses 
as the phosphorylation of IRF3 (Fig. 8B in I) or IFN-??????????????????????? 8A in I) 
did not take place in the influenza B virus-infected RIG-I-/- cells. In MDA5 deficient 
cells, influenza B induced IRF3 phosphorylation as well as in the wt cells, however, 
in influenza A virus-infected MDA5 knock-out cells IRF3 phosphorylation was 
reduced (Fig. 8B in I). Our results indicate that RIG-I is the essential receptor for the 
early influenza B virus-induced IFN activation. Thus influenza B virus infection 
resembles that of the highly pathogenic avian influenza virus (H5N1) infection, 
which induces robust and early RIG-I-dependent IFN responses in human 
macrophages (Hui et al., 2011). 
 
It is still not entirely clear, which influenza-derived ligands trigger RIG-I signaling 
in the context of infection. The question is not easy to answer as influenza viruses 
inhibit RIG-I recognition and RIG-I-induced signaling in many ways. In addition, 
influenza strains adapted to one host species may not show similar ability to restrict 
the activation of innate immune responses in the new host. The ds panhandle 
structure of influenza vRNP acts as a promoter region for viral replication and 
contains wobble pairs and mismatches and as such is not an optimal RIG-I ligand 
(Liu et al., 2015a). When stabilizing mutations were introduced to the panhandle, 
RIG-I activation and IFN induction were increased but viral mRNA synthesis was 
decreased (Liu et al., 2015a). As RIG-I is essential for inducing antiviral innate 
immune response against influenza, and since influenza virus is effectively blocking 
its functions, using optimized RIG-I agonists as prophylaxis against influenza has 
been studied (Chiang et al., 2015). Promising results have been obtained in mice by 
using these agonists as adjuvants in influenza vaccines (Beljanski et al., 2015). Virus 
like particle (VLP) vaccine, containing H5N1 HA and NA and the optimized RIG-I 
agonists as an adjuvant, greatly improved humoral and cellular immune responses to 
the vaccine and protected mice against lethal challenge with H5N1 virus (Beljanski 
et al., 2015). 
5.2.2 Influenza virus-induced IFN responses in human macrophages 
and DCs (II) 
In 2009 a novel swine origin H1N1 influenza virus caused a first influenza 
pandemic of the 21st century. As little was known about the characteristics of the 
pandemic H1N1 (pH1N1) virus in the human system, we decided to analyze the 
activation of IFN responses in human moDCs infected with the new virus. The 
Finnish virus isolate A/Finland/553/2009 used in the study was genetically almost 
identical to the initial isolate A/California/04/2009. The pH1N1virus readily infected 
moDCs (Fig. 1A in II) and replicated in moDCs with similar efficacy compared to 
the seasonal human H1N1 strains (Fig. 1B in II). When IFN gene expression was 
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studied, pH1N1 induced similar IFN mRNA levels as the seasonal human H1N1 
strains (Fig. 2A in II), however the levels were much lower than those induced by 
laboratory adapted strains A/WSN/33 (H1N1) and A/Udorn/72 (H3N2). 
Nevertheless, pH1N1-induced IFN-??? ???-?? ???? ???-?? protein production was 
barely detectable in moDCs, whereas seasonal H1N1 viruses or the H3N2 virus did 
produce IFNs (Fig. 2B in II). We also analyzed the infectivity and IFN gene 
expression in pH1N1-infected human macrophages in comparison to moDCs (Fig. 3 
in II) and found no significant differences between the cell types. 
 
Several in vitro studies have shown weaker (Chan et al., 2010; Mukherjee et al., 
2011; Patel et al., 2011; Zeng et al., 2011) or similar (Lee et al., 2010) immune 
responses in cells infected with the 2009 pandemic virus compared to the seasonal 
H1N1 virus-infected cells. Consistent with our study, pandemic H1N1 induced 
weaker IFN-?????????????????? ??????????????????????????????????????? ??????????-
adapted PR8 H1N1virus in human lung tissue (Wu et al., 2012). The authors showed 
that pandemic H1N1 virus suppressed RIG-I gene and protein expression but there 
was no difference in the proinflammatory response such as IL-6 gene expression. A 
comprehensive study analyzed the transcriptional response in human moDCs 
infected with pandemic H1N1 viruses (A/Brevig Mission/1/1918, 
A/California/4/2009) and seasonal H1N1 viruses (A/New Caledonia/20/1999, 
A/Texas/36/1991) (Hartmann et al., 2015). The authors showed that the 2009 
pandemic H1N1 virus induced lower IFN-?????????????????????????????????????????
H1N1 virus; however, the other seasonal H1N1 and the 1918 pandemic H1N1 
induced even lower IFN-????????????????? levels. ISGs were induced clearly slower 
during the 2009 pandemic H1N1 virus infection. They also found a cell response 
signature that distinguished the seasonal viruses from the pandemic viruses, as the 
seasonal viruses caused a dramatic mRNA loss in the host cell starting 4 hours post 
infection (Hartmann et al., 2015). Another transcriptional analysis comparing the 
early innate immune responses induced by the pandemic H1N1 virus 
(A/Mexico/4108/2009) to ones induced by a seasonal H1N1 virus 
(A/Brisbane/59/2007) stated that the pandemic H1N1 virus induced a stronger 
inflammatory response than the seasonal H1N1 in human bronchial epithelial cells 
(NHBECs) (Paquette et al., 2014). Similarly, in human macrophages the pandemic 
H1N1 virus showed higher proinflammatory cytokine expression compared to PR8 
H1N1 virus, but lower IFN-??????again, RIG-I expression was attenuated (Ramirez-
Martinez et al., 2013). 
 
Clearly there are significant virus strain- and host cell-specific differences in IFN 
and immune responses elicited by influenza A viruses. It may be that circumventing 
the early innate immune response and thus inducing less IFN in the host cells is 
crucial for successfull crossing of the species barrier. A recent paper indicated that 
the 2009 pandemic H1N1 virus is not able to subvert the innate immune responses in 
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porcine airway epithelial cells as efficiently as a true swine influenza virus (Krishna 
et al., 2015). The 2009 pandemic H1N1 strain replaced the seasonal H1N1 strains 
and still circulates among human population in addition to seasonal H3N2 and 
influenza B viruses. There is evidence that the pandemic H1N1 virus is acquiring 
human-adapting mutations which contribute to the severity of the virus infections in 
patients (Elderfield et al., 2014). 
5.2.3 Differences in the activation of innate immune responses by 
different influenza viruses (I, II) 
Apparently, influenza viruses activate innate immune responses differently and this 
variation has been studied from several perspectives: 1) differences between 
influenza A HA-NA subtypes, 2) pandemic vs. seasonal viruses, 3) avian influenza 
vs. human influenza, 4) low pathogenic avian influenza (LPAI) vs. HPAI viruses, 5)   
influenza A vs. influenza B viruses. It seems that in most cell types, influenza virus 
infection is sensed via RIG-I/MAVS/IRF3 pathway but the subsequent IFN 
responses elicited by the pathway differ in their kinetics and magnitude. Several 
mechanisms add to the complexity of the host-pathogen interactions. 
 
One reason for the differences between the virus-induced responses is that not every 
cell in the population responds similarly to the virus infection. There is stochasticity 
in every level of the cell signaling pathway commencing from the viral ligand 
recognition all the way to the transcription of IFN genes (Zhao et al., 2012). Only 
now the methods in biotechnology have begun to enable gene expression analysis at 
a single cell level, and advanced live-cell-imaging techniques have revealed cell 
population dynamics in virus infections. The reasons for the variability in single cell 
responses are largely unknown. Only a fraction of virus-infected cells produces IFNs 
and the paracrine signaling from the first infected cell affects the bystander cells 
(Patil et al., 2015). In addition, the host cell population context affects many aspects 
of virus infection; whether the cell is growing in the middle of the population or on 
the edge, what is the cellular state or cell density (Snijder et al., 2009). It is well 
known that IFNs increase the expression of PRRs and cell signaling components in 
PRR signaling pathways (Miettinen et al., 2001; Osterlund et al., 2005; Siren et al., 
2005; Siren et al., 2006; Tissari et al., 2005). The upregulation of several receptors 
and cell signaling components can sensitize the bystander cells and lower the 
threshold for virus-induced IFN expression. Even if IFN and maybe other cytokine 
responses induced by virus infection are stochastic in the cell population, IFNs 
induce ISGs in every cell via the JAK/STAT-pathway (Zhao et al., 2012). In the 
study by Zhao and coworkers, higher amounts of Sendai virus transcription and 
replication products and defective interfering particles were present in IFN 
producing cells. Another study using Sendai virus found out that virus MOI affects 
the IFN induction profile in cells (Zaritsky et al., 2015). This was dependent on the 
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differential activation of the JAK/STAT signaling via IFNAR by the different virus 
amounts. Thus when comparing different influenza strains, great care has to be taken 
in analyzing viral stocks, as differences in the infectivity of the stock virus may 
affect the results. Furthermore, if one influenza strain replicates more efficiently 
than the other, it may induce stronger and/or earlier IFN responses. 
 
The replication efficiency does not explain the differences in IFN expression 
between different influenza A viruses in this study (Fig. 2 in II) as all viruses 
replicated equally well in human moDCs (Fig. 1B in II). It is more likely that the 
viruses differ in their ability to inhibit IFN gene expression via their virulence 
factors or they carry genomic features aimed at evading the functions of host viral 
restriction factors. Several such features have been described for the 2009 pandemic 
H1N1 virus. The NS1 of the 2009 pandemic H1N1 efficiently inhibits IFN gene 
expression; however it is not able to block host gene expression (Hale et al., 2010). 
Yet, A/California/04/2009 strain expresses PA-X protein that mediates host cell 
shut-off and inhibits IFN-???????????????????????????????????????????(Hayashi et al., 
2015). The 2009 pandemic virus also carries mutations in NP protein that provide 
MxA resistance (Manz et al., 2013). The pH1N1 was highly sensitive to the antiviral 
actions of type I IFNs as shown by the IFN-dose dependent inhibition of viral M1 
gene expression (Fig. 4B in II) and cell surface glycoprotein expression (Fig. 4A in 
II) in moDCs. The inhibitory effect of IFN pretreatment was similar in pH1N1 virus 
infected cells and seasonal H1N1 virus-infected cells. Hence, when the antiviral 
state has been established in the cells, the host cell efficiently restricts the replication 
of the pandemic virus. This implicates that the pandemic H1N1 virus is not better 
than the seasonal H1N1 virus in evading the IFN-mediated host antiviral 
mechanisms. 
 
Although there is significant variance between different influenza virus infections in 
vitro, the clinical picture of influenza virus infections does not always vary 
accordingly. For example the HPAI H5N1 virus induces high IFN gene expression 
in the host; nevertheless the so-called cytokine storm is not protective but 
contributes to higher pathogenicity (de Jong et al., 2006). On the other hand, an 
avian influenza virus H7N9 that has caused severe disease in humans induces very 
low IFN responses in host cells (Arilahti et al., 2014). Intriguingly, the H5N1 and 
the pandemic H1N1 viruses have totally different phenotypes in TLR3 knock-out 
mice; in TLR3 deficient mice H5N1 is less pathogenic than in wt mice, whereas 
such a difference is not seen with the pandemic H1N1 virus (Leung et al., 2014). In 
the host organism many factors influence the outcome of the infection such as the 
transmission efficiency of the virus, the virus adaptation to the host including 
receptor binding, polymerase/replication efficiency, virulence factors, the interplay 
of different innate immune cells, the activation of adaptive immunity, possible cross 
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reacting antibodies against the virus, host genetic background and other yet 
unknown factors. 
5.3 TLR ligand-induced cytokine responses in human immune 
cells (III, IV) 
5.3.1 Cooperation of TLR signaling pathways 
During the infection, many different PAMPs are likely available for recognition by 
plethora of PRRs located in different cellular compartments. This redundancy allows 
for rigorous control over activation of innate immunity which is of utmost 
importance in clearing the infection but avoiding an inappropriate inflammatory 
response. Many studies have demonstrated that stimulating cells with two PRR 
ligands simultaneously leads to a stronger cytokine response than triggering only 
one receptor. However, only a limited number of genes is regulated by this synergy 
(Napolitani et al., 2005), one of the most studied being IL-12. We also wanted to 
address the question of synergy and what mechanisms regulate synergistic cytokine 
response in human moDCs and macrophages. 
 
First we analyzed the cytokine response in human moDCs (Fig. 1A in III) and 
macrophages (Fig. 1B in III) by stimulating them with a range of TLR ligands 
(Table 5) alone or pairwise. In moDCs TLR7/8 ligand R848 together with TLR3 
ligand polyI:C or TLR4 ligand LPS induced a synergistic IL-6, IL-10, IL-12p70 and 
TNF-???????????????????????????????????????????????????????????????????????????
alone induced a maximal cytokine response. When the cytokine gene expression was 
analyzed by qRT-PCR, also macrophages induced synergistic IL-6, IL-10 and IL-
12p35 gene expression at the late time point of 24 hours with the aforementioned 
TLR ligand combinations. In moDCs the synergy was evident earlier at 9 hour time 
point. In most studies synergy has been detected when a TLR that employs MyD88 
adaptor protein (all TLRs except TLR3) is combined with TLR that is coupled to 
TRIF adaptor (TLR3 or TLR4) (Bagchi et al., 2007; Bohnenkamp et al., 2007; 
Gautier et al., 2005; Hume et al., 2001; Napolitani et al., 2005; Sato et al., 2000b; 
Suet Ting Tan et al., 2013; Yi et al., 2001). Thus it has been postulated that both 
MyD88-dependent and TRIF-dependent pathways are needed for synergistic 
signaling. To support this hypothesis, it has been proposed that triggering TLR4, 
which activates both MyD88 and TRIF pathways, is a synergistic event on its own 
(Krummen et al., 2010). 
 
Most of the studies analyzing the synergy between different TLR receptors have 
been examining the proinflammatory cytokine responses. However, the endosomal 
TLRs recognizing nucleic acid structures are important in detecting viral infections. 
Therefore we wanted to study whether also IFNs are produced synergistically in 
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response to dual TLR stimuli.  Indeed, we detected synergistic IFN-??????-??????-
??? ???? ???-????? ????? ??????????? ??? ????????? ??? ????????????? ????????????? ???
LPS+R848 in moDCs (Fig. 1A in IV). However, the synergy was not evident in all 
three time points studied and in 3 hours polyI:C and LPS induced efficient IFN-??
and IFN-?????? ??????????????also analyzed IFN-?????? ???-??????????????????????
from the cell culture supernatants (Fig. 1C in IV). R848, which did not induce IFN 
gene or protein expression alone, augmented polyI:C-induced cytokine production. 
In addition, when IL-12p70 and IFN-????????????????????????????????????????????
after stimulation with polyI:C+R848 and LPS+R848 with several concentrations, 
IFN-??? ???????? ??????????????? ???????? ????????????????? ???????? ?????? ???? ??? ???
R848 increased IFN-?????????????pression only weakly (Fig. 5, polyI:C lower panel 
on the left, LPS lower panel on the right, unpublished).  However, polyI:C or LPS 
did not induce IL-12p70 alone but dose-dependently increased R848-induced IL-
12p70 production (Fig. 5, upper panels, unpublished). Clearly, IL-12p70 and IFNs 
are regulated differently by the synergistic TLR pathways. 
 
 
Figure 5. Dose response of dual TLR ligand stimulation in moDCs. Cell culture 
supernatants were harvested from moDCs of three blood donors after stimulation with different 
TLR ligand combinations for 24 hours with concentrations indicated in the figure. IL-12p70 
and IFN-?????????????????????????????????????????????????? kits and the data is presented as 
the means +SD. PolyI:C+R848 on the left panels, LPS+R848 on the right panels. 
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A recent paper showed that in murine antigen presenting cells, preconditioning cells 
with polyI:C augmented IFN-?? ???? ???-?? ??????????? ??????? by R848 or TLR9 
ligand CpG DNA (Hotz et al., 2015). The authors also stated that although 
pretreatment with polyI:C increased the cytokine responses induced by another TLR 
ligand, it inhibited subsequent RLR signaling. In addition, the effect was seen with 
virus infection which also sensitized the cells for TLR signaling but inhibited 
signaling via RLR pathway. The authors discussed that after the initial virus 
infection, blocking of RLR signaling and the sensitizing of TLR7 pathway would 
serve to induce efficient IL-12 production and subsequent Th1 cell differentiation. 
Our results support this theory, as in our human cell model polyI:C increased TLR7 
and TLR8 expression (Fig. 3A in IV) and IL-12p70 protein was produced efficiently 
with  R848 whereas polyI:C alone induced very little IL-12p70 (Fig. 5, upper left 
panel). Whether polyI:C treatment can also block the RLR signaling pathway in the 
human system requires further studies. 
5.3.2 Transcriptional regulation of IL-12 and IFN-?1 genes 
We went on studying the mechanism of IL-12 synergy in human immune cells. 
Previously it had been proposed that sustained MAPK c-Jun (Napolitani et al., 2005) 
or MAPK p38 (Bohnenkamp et al., 2007) signaling is taking place in moDCs 
stimulated with polyI:C+R848. Furthermore, IFN autocrine-paracrine loop was 
shown to be involved in the synergistic effect (Gautier et al., 2005). As the promoter 
region of IL-12p35 was already analyzed (Goriely et al., 2006; Liu et al., 2003; Liu 
et al., 2004) we carried out oligonucleotide precipitation experiments to analyze the 
binding of transcription factors to the IL-12p35 ISRE and NF-?????????????????????
in human moDCs and macrophages. In moDCs, polyI:C or R848 both induced the 
binding of several IRF and STAT proteins to the ISRE site, but polyI:C-induced 
binding was stronger and took place at earlier time points than R848-induced 
binding for all IRFs studied except IRF8 (Fig. 4A in III). In contrast, in 
macrophages polyI:C did not induce the binding of IRF1, IRF3, IRF9 or STAT1 
onto IL-12p35 ISRE site (Fig. 5A in III).  R848, however induced the binding of 
IRF1 and IRF3, and the binding of IRF7 and IRF8 was stronger in R848-stimulated 
cells compared to polyI:C stimulated cells (Fig. 5A in III). Altogether, we did not 
observe a synergistic binding of transcription factors to the ISRE site in 
polyI:C+R848 stimulated moDCs but in macrophages the binding of IRF1, IRF7, 
IRF9 and STAT1 were induced better with the dual stimulus compared to a single 
stimulus. In moDCs the transcription factor activation took place earlier than in 
macrophages and was induced via both polyI:C and R848 reflecting the earlier and 
much stronger IL-12p35 gene expression seen in Fig. 2 in III. IRF1 (Liu et al., 2003), 
IRF3 (Goriely et al., 2006) and IRF8 (Liu et al., 2004) have been shown to be 
important for IL-12p35 gene expression and our results confirm these findings. 
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We also studied IRF1, IRF7 and IRF8 binding to the IFN-?????????????????????????
moDCs and the polyI:C+R848 stimulus induced a stronger binding of all these IRFs 
compared to stimulation with a single ligand (Fig. 6A in IV). Consequently, at the 
transcriptional level the activation of multiple IRFs via TRIF- and MyD88-
dependent pathways may contribute to the synergy. A very recent paper analyzed 
polyI:C+R848-induced synergistic IL-12p40 and IL-6 gene expression in murine 
macrophages and showed with oligonucleotide precipitation and siRNA experiments 
????? ?????? ????? ???? ??????? ?????????????? ??ctors were responsible for the 
synergistic effect (Liu et al., 2015b). Probably, in the case of many cytokines, the 
synergy is regulated at the transcriptional level. Yet an additional enhancing 
mechanism requires attention and that is chromatin remodeling. Qiao and coworkers 
showed that IFN-?? ??? ????? ??? ?????? ?????????? ??? ????????? ?? ?????????? ???????? ???
STAT1 and IRF1 to the TNF, IL-6 and IL-12p40 gene promoter and enhancer 
regions (Qiao et al., 2013). The priming alone did not induce transcription but 
enhanced the transcription induced by TLR4 stimulation synergistically. We noticed 
that polyI:C+R848-stimulation induced ~400 fold induction of IFN-??mRNA and up 
to 100 pg/ml IFN-?? ??????? production in moDCs from some donors (data not 
shown). Thus IFN-?-dependent chromatin remodeling may well be a contributing 
factor in the TLR synergy and it remains to be investigated, whether other IFNs 
have similar effects. 
 
Many of the MAPK signaling components have been linked to the synergistic 
cytokine expression. We analyzed the involvement of different MAPK signaling 
pathways in moDCs with immunoblot analysis of phosphorylated signaling 
components and treating cells with pharmacological inhibitors. Both polyI:C and 
R848 induced the phosphorylation of p38, c-Jun (JNK-pathway) and Akt (PI3K-
pathway) (Fig. 6A in III). p44/p42 (ERK-pathway) was constitutively 
phosphorylated until a 9 hour time point, where the phosphorylation declined in the 
polyI:C- and R848-stimulated cells. Inhibitors of NF-????????????????????????????
abolished the TLR ligand-induced IL-12p35 gene expression (Fig. 6B in III) and IL-
12p70 protein expression (Fig. 6C in III) but also JNK and ERK inhibitors reduced 
IL-12 expression to some extent. A study using mouse bone marrow-derived DCs 
showed an identical inhibition pattern for IL-12p70 induced with LPS+R848 
(Mitchell et al., 2010). We did not observe sustained c-Jun phosphorylation 
(Napolitani et al., 2005), p38 phosphorylation (Bohnenkamp et al., 2007) or ERK 
phosphorylation (Suet Ting Tan et al., 2013) with polyI:C+R848 stimulus, however 
we confirm that all these pathways play a role either directly or indirectly in TLR 
ligand-induced cytokine gene expression. 
 
Very little is known about MAPK pathways in the context of IFN gene expression 
and it has been thought that IFN gene expression is regulated mainly via IRF, STAT 
and NF-???????????????? ??????????????????? ??????????????????? ?????????? ??????
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and measured polyI:C and R848-induced IFN-?? ???? ???-??? ????? ????????????
Inhibition of PI3K and p38 pathways abolished the TLR-induced IFN gene 
expression (Fig. 7 in IV). Interestingly, H5N1 influenza virus-induced IFN-?? ????
IFN-????????????????????????????????????????????????????????????????????????????
(Hui et al., 2009) and similarly p38 inhibition reduced H5N1 virus induced IFN-??
gene expression in endothelial cells (Borgeling et al., 2014). In addition, a recent 
extensive study indicated that PI3K and especially p38 pathways have roles in IFN-
?????????????????????????????????????????????????? molecules (Jiang et al., 2015).  
Clearly, more research into the vast network of different MAPK pathways is needed 
to clarify their role in IFN gene expression. 
5.3.3 IFN feedback loop in the cooperation of TLR signaling pathways 
There are different views of the importance of IFN feedback loop in the cooperation 
of TLRs. Two groups claimed that IFNs are not responsible for the mechanism of 
synergy, as stimulating the cells with exogenous IFN-?????????????????????????????
did not substantially increase IL-12p70 (Napolitani et al., 2005) or TNF (Bagchi et 
al., 2007) production. Gautier and colleagues, however, showed that in STAT1 or 
IFNAR knock-out mouse macrophages, synergistic IL-12p70 production was greatly 
reduced thus pointing to the dependence on IFN feedback loop (Gautier et al., 2005). 
We studied the synergistic IL-12p35 and IL-12p40 gene expression in moDCs in the 
presence of IFN-????? ???-??????????????????????????? ??????????????????????????? ???
the TLR3 or TLR4 ligands are added before the TLR7/8 ligand (Napolitani et al., 
2005; Suet Ting Tan et al., 2013). Moreover, polyI:C and LPS but not R848 induce 
a rapid  IFN-?????????-??????????????????????????????? ????????? ?????? ???????????
took a different approach and instead of stimulating the cells with IFNs 
simultaneously with the TLR ligands we primed moDC with IFN-????????-?? for 4 
hours prior to TLR stimulation. The priming increased TLR-induced IL-12p35 and 
IL-12p40 gene expression (Fig. 6, unpublished), IFN-??????????????y than IFN-????
In addition, the priming augmented IFN-?????????-?????????????????????????????????
5B in IV). Treating moDCs with antisera against IFN-??????????????????????????-
induced IFN-?????????-?????????????????n to some extent (Fig.4 in IV). 
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Figure 6. Priming with IFN increases synergistic IL-12 gene expression in moDCs. Human 
moDCs from four blood donors were primed with IFN-????????????????????-????????????????????
hours after which the cells were stimulated with poly???? ???? ???????? ????? ???? ???? ??? ??????
combinations for an additional 8 hours. The cells were pooled and total cellular RNA was isolated 
for cDNA synthesis and qRT-??????????????????????????????????????????????????-actin mRNA 
and relative mRNA levels were c???????????????????-method using untreated cells as a calibrator. 
As we know that the expression of TLR3 and TLR7 in human moDC is rather low 
but induced by IFNs (Osterlund et al., 2005), we studied the TLR gene expression in 
response to TLR ligand stimulation. PolyI:C induced the expression of TLR3, TLR4, 
and TLR8 but especially that of TLR7 (Fig. 3A in IV). The polyI:C-induced IFN 
contributed to TLR gene expression as priming with IFN-?? ??? ???-??? ??????????
TLR3, TLR7 and TLR8 gene expression (Fig. 5A in IV) and anti-IFN-???? ???a 
reduced TLR7 gene expression (Fig. 3B in IV). We propose that triggering the 
TLR3/TRIF pathway induces a rapid IFN gene expression which upregulates TLR 
and IRF7 (Fig. 5A in IV) expression and sensitizes the cells to TLR7/8 ligation and 
also amplify the TLR3 pathway signaling, leading to higher IFN-??????-???and IL-
12 expression (Fig. 7). Supporting our hypothesis a very recent study using sorted 
human BDCA+ DCs and pDCs showed that IFN-dependent upregulation of TLR7 
(BDCA+ DCs) or TLR3 (pDCs) was involved in synergistic IL-6 production 
induced by R848 and polyI:C (Kreutz et al., 2015). 
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Figure 7. A proposed model for TLR synergy. First, triggering the TLR3 and TLR7/8 pathways 
leads to the activation of IRF-, MAPK- and NF-??-pathways. The TLR7/8/MyD88-pathway 
induces the IL-12p35 expression and the TLR3/TRIF pathway induces IFN gene expression. The 
autocrine IFN signaling activates ISGF3 (STATs+IRF9) transcription factor that subsequently 
activates TLR7 and IRF7 gene expression and protein production. These will further amplify the 
TLR signaling pathways leading to stronger signaling and higher production of IFNs and IL-12p35 
in later time points. 
In summary, the synergistic activation of TLRs takes place when both MyD88- and 
TRIF-dependent pathways are triggered. These pathways lead to the activation of 
partially overlapping signaling cascades (Fig. 3) leading to an optimal activation of 
IRF, NF-?? and MAPK-pathways. IFNs induced mainly via TRIF-dependent 
pathway further enhance the synergistic cytokine gene expression by upregulating 
TLRs and downstream components of the signaling pathways such as transcription 
factors. The production of proinflammatory cytokines and IFNs can however lead to 
immunopathology. That is why the host must carefully control the expression of 
these mediators and induce the production only if the pathogen is sensed via 
different receptors in several cellular compartments. Furthermore, both positive and 
negative feedback loops in the cell signaling offer means of rigorous regulation. 
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6 Concluding remarks 
In this thesis influenza virus- and TLR ligand-induced IFN and cytokine gene 
expression was studied in human primary macrophages and moDCs. We studied the 
very early virus-host interaction and induction of IFNs by influenza B virus in 
human macrophages. We found clear differences in the early innate immune 
activation by influenza B virus compared to influenza A virus. Influenza B virus 
induced early IFN gene expression and IRF3 activation upon entry into 
macrophages. In contrast these early responses were absent in influenza A virus-
infected macrophages. Furthermore, we characterized IFN responses induced by 
different H1N1 influenza viruses compared to the novel 2009 pandemic H1N1 
influenza and showed that the pandemic virus was highly sensitive to the actions of 
IFNs. Finally, we found differences between cell types (macrophages vs. moDCs) in 
the regulation of TLR ligand-induced cytokine gene and protein expression. MoDCs 
were more potent inducers of the synergistic IL-12 cytokine expression compared to 
macrophages and the difference was reflected to the transcription factor activation 
induced by different TLR ligands. Our studies illuminated and further confirmed cell 
signaling mechanisms involved in the synergistic IL-12 and IFN gene expression in 
the human system. 
 
Despite the great advances in elucidating mechanisms of innate immune system 
activation during the past decade, many unanswered questions remain. There is still 
a great many receptors without known ligands and most likely additional PPRs are 
still to be found. Even though many innate immune signaling pathways are well 
defined, controversy exists, not least because of cell-type or organism-specific 
regulation. We have just started to realize the complexity of host-pathogen 
interactions of seemingly simple pathogens, such as viruses. The multitude of 
different receptors, signaling pathways and cytokines forming complex networks 
sets up a need for systems biology approach. A great deal of basic research into the 
innate immunity is necessary to establish the framework for further translational 
research. 
 
The advantages of defining PRR-triggered cell signaling pathways leading to the 
activation of innate immunity are numerous. Already various types of TLR ligands 
are used as vaccine adjuvants (Maisonneuve et al., 2014) and in the future, cocktails 
of different PRR ligands could be used to induce optimal humoral and cellular 
immunity. Secondly, efficient DC-activating adjuvants are greatly needed for the use 
of DC-based therapy against cancer (Bloy et al., 2014). Thirdly, TRL7/8 ligand 
Imiquimod is already in use for the treatment of warts and skin cancer, thus detailed 
knowledge of PRR signaling pathways may give rise to additional antiviral or 
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anticancer treatment modalities. Fourthly, thorough understanding of influenza 
virus-induced cytokine gene expression may shed light on the mechanisms of 
hypercytokinemia induced by highly pathogenic influenza viruses and direct the 
development of novel cures for infectious diseases in general. Finally, it is becoming 
increasingly clear that the innate immune responses are closely coupled to almost 
every human disease including autoimmune diseases, infectious diseases and cancer. 
Elucidating the mechanisms of host-pathogen interactions and innate immunity is 
crucial for learning to manipulate these mechanisms for the benefit of human health. 
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